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Abstract 
Psychosis is usually preceded by a prodromal period. This phase is characterized by 
psychotic-like symptoms, attenuated positive symptoms not severe enough to reach a 
psychotic level, preceding the onset of full-blown psychotic symptoms. For example, a 
person may hear voices that are not real. However, psychotic-like symptoms are 
common among adolescents, especially among those with other psychiatric symptoms, 
and they are not necessarily indicative of the psychosis prodrome.  
This study addresses symptoms that based on previous research may be associated 
with a heightened risk for psychosis. By finding which symptoms predict transition to a 
severe psychiatric illness during the following months or years, these risk symptoms can 
be identified early, and effective interventions can attenuate, delay or even prevent the 
onset of a psychotic disorder. 
The objective of the study was to investigate whether it is possible and useful to 
screen for psychosis risk in an unselected clinical adolescent population seeking help for 
psychiatric symptoms. The study wanted to gain information on the character and 
prevalence of psychotic-like symptoms and to investigate which symptoms predict 
psychosis and hospitalizations among adolescents in general psychiatric care. In 
addition, the associations between psychosis risk symptoms, cognitive functioning, and 
suicidal ideation and behavior were investigated. 
This study collected data on adolescent psychiatric patients aged 15–18 years in 
Helsinki during the years of 2003–2004 and 2007–2008. The participants were screened 
using the Prodromal Questionnaire (PQ) for prepsychotic symptoms, which was 
completed by 731 adolescents. The Structured Interview for Prodromal Syndromes 
(SIPS) was administered to 174 adolescents to ascertain their psychosis risk status, and 
broad cognitive testing was done. The participants were followed via patient files and 
the national hospital discharge register.  
The adolescents with high-risk symptoms had deficits in their cognitive functioning 
which were associated with stronger negative symptoms. Particularly poorer verbal 
performance was associated with stronger negative symptoms among adolescent 
patients, regardless of the psychosis risk status. Visuospatial performance was poorer 
among the adolescents with a psychosis risk compared to other patients. 
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A third of the participants in general adolescent psychiatric services were identified 
as psychosis risk patients, but psychosis incidence during follow-up was low, and the 
psychosis risk status was not specifically predictive of psychosis. Hospital admissions 
for psychotic disorder were predicted by the depersonalization symptom intensity of the 
questionnaire and the positive symptom intensity of the interview. In addition, 
psychosis risk status predicted psychiatric hospitalizations overall during the following 
years.  
Psychotic-like experiences were associated with suicidal ideation among the 
adolescent psychiatric patients, but they did not predict an increased risk of severe, 
hospital-treated self-harm during follow-up. The best predictor of intentional self-harm 
was emotional inexpressivity. 
Psychotic-like symptoms are common among adolescent psychiatric patients, but the 
development of psychosis is rare, and predicting psychosis with psychotic-like 
symptoms is not possible in the clinical environment. However, identifying and treating 
psychotic-like symptoms is important, as not only are they often distracting experiences 
in themselves, they can also be associated with cognitive deficits and suicidality, predict 
hospitalizations, and thus indicate a more serious disorder. 
 7 
 
Tiivistelmä 
Maija Lindgren: Psychotic-like symptoms and psychosis prediction in adolescent 
psychiatric patients [Psykoottisenkaltaiset oireet ja psykoosin ennustaminen 
nuorisopsykiatrisilla potilailla] 
 
Psykoosia edeltää tavallisesti niin sanottu prodromaali- eli esioirevaihe. Tälle vaiheelle 
ovat ominaisia psykoottisenkaltaiset oireet, vaimentuneet psykoottistasoisia oireita 
lievemmät positiiviset oireet, jotka edeltävät täysimittaisten psykoottisten oireiden 
alkamista. Henkilö voi esimerkiksi kuulla ääniä, jotka eivät ole todellisia. 
Psykoottisenkaltaiset oireet ovat kuitenkin tavallisia nuorilla, erityisesti muuten 
psykiatrisesti oireilevilla nuorilla, eivätkä ne välttämättä ole oire alkavasta psykoosista.  
Tässä tutkimuksessa tutkitaan oireita, jotka aikaisempien tutkimusten mukaan voivat 
liittyä kohonneeseen riskiin sairastua psykoosiin. Kun saadaan tietää mitkä oireet 
ennustavat henkilön sairastumista vakavaan mielenterveyden häiriöön lähikuukausina 
tai -vuosina, voidaan näiden riskioireiden tehokkaalla hoidolla viivästyttää tai jopa 
ennaltaehkäistä psykoottisen häiriön puhkeamista tai lieventää kehittyvää häiriötä.  
Tutkimuksen tarkoitus oli selvittää, onko psykoosiriskiä mahdollista ja hyödyllistä 
seuloa valikoitumattomassa aineistossa sellaisten nuorten parissa, jotka ovat hakeneet 
apua mielenterveyden oireisiin. Tutkimuksessa haluttiin kartoittaa nuorisopsykiatristen 
potilaiden psykoottisenkaltaisia oireita, niiden luonnetta ja yleisyyttä, ja selvittää mitkä 
oireet ennustavat psykooseja ja sairaalahoitoja. Myös psykoosiriskioireiden yhteyttä 
kognitiiviseen suoriutumiseen sekä itsemurha-ajatuksiin ja itsetuhoiseen 
käyttäytymiseen tutkittiin. 
Aineisto kerättiin nuorisopsykiatrisilta 15–18-vuotiailta potilailta Helsingissä 
vuosina 2003–2004 ja 2007–2008. Tutkittavat seulottiin käyttäen esipsykoottisia oireita 
mittaavaa PQ-itseraportointilomaketta (suom. NKK), jonka täytti 731 nuorta. 174 
nuoren psykoosiriskiä tutkittiin srukturoidulla SIPS-haastattelulla ja tutkittaville tehtiin 
laaja kognitiivinen testaus. Potilaita seurattiin sairaskertomusten ja 
hoitoilmoitusrekisterin avulla.  
Riskioireilevilla nuorilla oli kognitiivisen suoriutumisen vaikeuksia, jotka olivat 
yhteydessä vaikempiin negatiivisiin oireisiin. Erityisesti nuorisopotilaiden heikentynyt 
kielellinen suoriutuminen oli yhteydessä voimakkaampiin negatiivisiin oireisiin 
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riippumatta siitä, täyttyivätkö psykoosiriskikriteerit. Visuospatiaalinen suoriutuminen 
oli heikompaa psykoosiriskikriteerit täyttävillä nuorilla kuin muilla potilailla. 
Valikoitumattoman nuorisopykiatrisen aineiston tutkittavista kolmasosa täytti 
psykoosiriskikriteerit, mutta psykoosiin sairastumiset seuranta-aikana olivat harvinaisia 
ja psykoosiriskistatus ei ennustanut spesifisti psykoosia. Sairaalahoitoja psykoosin 
vuoksi ennustivat kyselylomakkeen mittaamat depersonalisaatio-oireet ja haastattelun 
mittaamat positiiviset oireet. Psykoosiriskistatus taas ennusti ylipäänsä lähivuosien 
psykiatrisia sairaalahoitoja.  
Psykoottisenkaltaiset kokemukset olivat yhteydessä itsetuhoisiin ajatuksiin 
nuorisopsykiatrisilla potilailla. Psykoottisenkaltaiset oireet eivät kuitenkaan ennustaneet 
seuranta-ajan vakavia, sairaalahoitoa vaativia tahallisia itsensä vahingoittamisia. 
Parhaiten itsetuhoista käyttäytymistä ennusti vähentynyt tunteiden ilmaisu.  
Psykoottisenkaltaiset oireet ovat nuorisopsykiatrisilla potilailla yleisiä mutta 
psykoosiin sairastuminen harvinaista, eikä sairastumisen ennustaminen 
psykoottisenkaltaisten oireiden perusteella ole kliinisessä työssä mahdollista. 
Psykoottisenkaltaisten oireiden tunnistaminen ja hoitaminen on kuitenkin tärkeää, sillä 
sen lisäksi että ne usein ovat itsessään häiritseviä kokemuksia, ne voivat olla yhteydessä 
kognitiivisiin puutoksiin ja itsetuhoisuuteen, ennustaa sairaalahoitoja, ja siten kertoa 
vakavammasta sairaudesta. 
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1 Introduction 
Early recognition of emerging mental health disorders has become a priority in the field 
of psychiatry (Coughlan et al., 2013). First signs of many psychiatric illnesses can 
already be detected during the premorbid period, enabling early intervention. The earlier 
the problems are treated, the greater the chance of a successful recovery (van der Gaag 
et al., 2013). The World Health Organization (WHO, 2004; 2013) states the prevention 
of mental disorders as a public health priority. 
Severe psychiatric disorders usually develop gradually and are often preceded by a 
prodromal phase (Häfner et al., 2005; McGlashan, 1996; Yung & McGorry, 1996). The 
symptoms of this phase not only include general symptoms, such as sleeping problems, 
depressive mood, social withdrawal, and problems in school or work, but also include 
attenuated positive symptoms, such as suspiciousness and perceptual abnormalities. The 
prodromal symptoms cause distress and suffering a long time before the actual illness, 
and psychosocial functioning often declines years before the first psychotic symptoms 
and the initiation of treatment (Addington, Penn, Woods, Addington, & Perkins, 2008; 
Häfner, Loffler, Maurer, Hambrecht, & an der Heiden, 1999). The clinical high-risk 
approach aims to predict transition to psychosis by clinically significant risk symptoms 
that do not meet the threshold of psychotic disorder (Addington & Heinssen, 2012).  
The delay between the onset of symptoms and treatment onset is linked with poorer 
outcome (Penttilä, Jääskeläinen, Hirvonen, Isohanni, & Miettunen, 2014), and hence, 
one goal of early treatment is to shorten the duration of untreated psychosis (Häfner & 
Maurer, 2006; Larsen et al., 2001). Early recognition and treatment are emphasized in 
the Finnish recommendations for schizophrenia care (Schizophrenia: Current Care 
Guidelines). Further, the clinical high-risk approach aims to detect and effectively treat 
risk symptoms early in order to prevent or delay the onset of psychosis, and to reduce 
the severity of the prodromal symptoms (McGorry et al., 2002; Morrison et al., 2012; 
van der Gaag et al., 2013; Walker et al., 2009). Even postponing the transition to 
psychosis in adolescence is valuable, because of the leaps in maturation of the brain and 
the development of social relationships and academic skills. Psychosis risk symptoms 
also cause distress themselves, thus reliable methods to detect vulnerability to psychosis 
are needed (Salokangas & McGlashan, 2008).  
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1.1 Psychosis 
Psychotic disorders are severe mental disorders characterized by behaviors and 
experiences that make it difficult to understand reality. These include delusions (false 
beliefs), hallucinations (perceiving things that are not real), and disorganization 
(including disturbed and confused thoughts, speech, or behavior). These symptoms, 
which most individuals do not normally experience but are present in a psychotic 
disorder, are called positive symptoms. Also common in psychotic illnesses are negative 
symptoms, functions normally found in healthy persons, but diminished or absent in 
affected persons. These symptoms include withdrawal from friends and family, 
impoverishment of thoughts and speech, and flattening of affect. In the latest update of 
the Diagnostic and Statistical Manual of Mental Disorders, DSM-5 (American 
Psychiatric Association, 2013), the dimensional assessment of psychosis includes 
hallucinations, delusions, disorganized speech, abnormal psychomotor behavior, and 
negative symptoms. As novel dimensions, depression, mania and impaired cognition are 
also assessed as part of psychotic illnesses (Barch et al., 2013). 
Psychotic disorders cause great suffering and affect relationships, education and 
work, and quality of life. Psychotic disorders classified in DSM-5 are listed in Table 1. 
The most common psychotic disorder is schizophrenia, the prevalence being 
approximately 1% in Finland (Perälä et al., 2007). Schizophrenia is characterized by 
delusions and hallucinations, as well as disorganized speech and behavior, causing 
social or occupational dysfunction. For a diagnosis, symptoms and functional 
impairment must have been present for six months. Schizophrenia is often associated 
with significant deficits and need for help in everyday functioning (Viertiö et al., 2012).  
Other psychotic disorders include schizophreniform disorder, schizoaffective 
disorder, delusional disorder, brief psychotic disorder, and other specified schizophrenia 
spectrum and other psychotic disorder. In addition, schizotypal personality disorder is 
classified as a schizophrenia spectrum disorder. Bipolar disorder and depressive 
disorder, categorized in mood disorders, can also occur with psychotic features. 
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Table 1. Psychotic disorders according to DSM-5 
Disorder Specifiers 
Schizophrenia  
 
Delusions, hallucinations, disorganized speech and 
behavior, for six months, causing social or occupational 
dysfunction 
Brief psychotic disorder Delusions, hallucinations, disorganized speech and 
behavior, for less than one month 
Schizophreniform disorder Delusions, hallucinations, disorganized speech and 
behavior, for more than one month but less than six 
months 
Delusional disorder Delusions for one month, hallucinations not prominent, 
functioning not markedly impaired 
Schizoaffective disorder Features of both schizophrenia and a mood disorder, either 
bipolar disorder or depression 
Substance or medication induced 
psychotic disorder, Psychotic disorder due 
to another medical condition 
Psychotic disorder explained with substance use, 
medication, or a medical condition 
Catatonic disorder Psychomotor disturbance; associated with another disorder 
or medical condition, or unspecified catatonia 
Other specified schizophrenia spectrum 
and other psychotic disorder 
Psychotic disorder not specified 
Unspecified schizophrenia spectrum and 
other psychotic disorder 
Psychotic disorder, with insufficient information for a 
specific diagnosis 
 
1.1.1 Epidemiology of psychotic disorders 
In a study of the whole population of Denmark, 3.7% of women and 3.8% of men were 
estimated to have received treatment for schizophrenia and related disorders over their 
lifetime (Pedersen et al., 2014). Similarly, in a comprehensive study using multiple 
information sources, the lifetime prevalence of psychosis was over 3% in the general 
population in Finland (Perälä et al., 2007). 
As for adolescents, the cumulative incidence of schizophrenia spectrum disorders 
(International Classification of Diseases, 10th edition, ICD-10 codes F20–F29) by the 
age of 20 in Denmark was 0.73% (95% CI 0.70–0.75) for women and 0.65% (95% CI 
0.63–0.68) for men (Pedersen et al., 2014). The corresponding rates for schizophrenia 
(ICD-10 F20) were 0.29% (95% CI 0.28–0.31) for women and 0.33% (95% CI 0.31–
0.35) for men. By the end of 25 years of age, the cumulative incidence of schizophrenia 
spectrum disorders rose to 1.33% (95% CI 1.30–1.37) in women and to 1.48% (95% CI 
1.44–1.51) in men, the corresponding rates for schizophrenia being 0.66% (95% CI 
0.64–0.69) for women and 0.80% (95% CI 0.78–0.83) for men.  
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Although there are no gender differences in the incidence of schizophrenia during 
childhood and adolescence, in adulthood the incidence per 10 000 person-years is 
higher for men until at age 50, when the women’s incidence becomes higher (Pedersen 
et al., 2014). 
These rates are consistent with results of cohort studies in Finland. In the Northern 
Finland 1986 birth cohort study, adolescents between ages 17 and 23 years, who had 
completed the PROD-screen (a screen for prodromal symptoms of psychosis) at age 15 
to 16, were followed via the Finnish Hospital Discharge Register (Mäki et al., 2014). 
0.4% of the sample was diagnosed with psychosis during follow-up, out of which 0.3% 
were non-affective psychoses (Mäki et al., 2014). In the Finnish 1981 birth cohort 
study, 1.5% of the males and 0.8% of the females were treated for psychosis between 
the ages of 13 to 24 years according to the Finnish Hospital Discharge Register 
(Gyllenberg et al., 2010). The cumulative incidence for non-affective psychoses was 
1.3% for males and 0.5% for females (Gyllenberg et al., 2010).  
Compared to first-episode psychosis patients with onset after 18 years, adolescent 
onset patients tend to have a slower onset of symptoms and experience a longer delay in 
access to treatment (Joa et al., 2009). This group may have worse premorbid functioning. 
Teen onset of psychosis may also be associated with higher levels of depression and 
suicidal ideation and suicide attempts (Joa et al., 2009). 
 
1.2 The prodromal phase of psychosis and psychotic-like 
symptoms  
The prodromal phase, which often precedes psychosis 1–2 years before the first 
admission (Salokangas & McGlashan, 2008), provides an opportunity to detect a 
disease course, predict psychosis and to possibly intervene before frank disease 
(Addington & Heinssen, 2012; Mees, Zdanowicz, Reynaert, & Jacques, 2011). The 
prodromal phase of psychosis is characterized by psychotic-like symptoms, which are 
attenuated positive symptoms not severe enough to reach a psychotic level (Rietdijk et 
al., 2014; Yung et al., 2009).  
As an example of these mild positive symptoms, a person may occasionally have 
perceptual distortions, for example hear voices, but realizes that they are not real. Or a 
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person may be distracted by the feeling that others can read his or her mind but is not 
sure if it is really happening or if it is imaginary, so the delusional idea does not reach 
the psychotic level. The difference between psychotic and psychotic-like symptoms lies 
in reality testing and conviction of the experience being real. Typically, in a psychotic 
disease course, psychotic-like symptoms gradually get stronger, finally reaching the 
psychotic level. However, the predictive value of single psychotic-like experiences is 
low. 
Table 2 presents the basic concepts of psychosis risk research. It has to be noted that 
the term prodrome can be misleading, as it can only be correctly used retrospectively; 
not all patients classified as being at psychosis risk ever develop psychosis.  
A current controversy is the boundary between normal experience and psychosis risk 
symptoms (Yung & Nelson, 2013). Psychotic experiences can be seen as a continuum, 
with full clinical psychosis representing the extreme (Linscott & van Os, 2010; van Os, 
Linscott, Myin-Germeys, Delespaul, & Krabbendam, 2009). From this perspective, 
psychotic symptoms are not qualitatively different from normal experiences. People 
with psychosis and healthy people can therefore have the same experiences, but to a 
different degree.  
As normal variation in the psychosis continuum, mild psychotic-like experiences, 
such as perceptual abnormalities of a healthy person, are not clinically relevant if they 
come and go and do not interfere with functioning in everyday life. In stressful 
situations associated with sleep deprivation, trauma, drugs, or bereavement following 
xxx 
Table 2. Concepts of psychosis risk research 
Concept Specifiers 
Psychotic-like symptoms Attenuated positive symptoms under psychotic threshold 
Prodrome / prodromal phase Retrospective concept of the symptomatic phase before onset of frank 
psychosis; phase of prodromal symptoms 
Psychosis risk Heightened risk for psychosis, either symptomatic risk (psychosis risk 
symptoms) or genetic (familial) risk  
Basic symptoms Early prodromal phase; subtle, self-experienced anomalities in 
cognition and perception 
Psychosis risk syndromes: 
 clinical high-risk 
(CHR) 
 ultra high-risk 
(UHR) 
Late prodromal phase, symptomatic approach; 
operationalizations of psychosis risk:  
 attenuated positive symptoms (APS) OR 
 brief limited intermittent psychotic symptoms (BLIPS) OR 
 lowered functioning in addition to schizotypal personality or 
familial risk to psychosis (GRD) 
Genetic high-risk Heightened risk for a psychosis in case of family history of psychosis 
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the loss of a loved one, anyone can have transitory psychotic experiences at some stage 
in their lives. Psychotic-like symptoms that are milder than in clinical psychotic 
disorders are common in the general population (Rössler et al., 2007; Schultze-Lutter, 
Michel, Ruhrmann, & Schimmelmann, 2014; van Os et al., 2009; Werbeloff et al., 
2012), especially among children and adolescents (McGorry et al., 1995; Yung et al., 
2009), the prevalence declining from childhood into adolescence (Brandizzi et al., 2014). 
In the Northern Finland 1986 birth cohort, psychotic-like experiences were commonly 
reported in the PROD-Screen questionnaire by 15–16-year-old adolescents from the 
population, with endorsement frequencies up to 35% (Mäki et al., 2014; Therman et al., 
2011). In an Australian study, 8.4% of the adolescents in the population had 
hallucinations, as assessed with questionnaire and clinical evaluation of a written 
description of the experience (Scott et al., 2009). According to a meta-analysis, the 
median prevalence of psychotic(like) symptoms in 13–18-year-old adolescents in the 
community was 7.5% (Kelleher et al., 2012). 
From adolescence to adulthood, the experiences get rarer (Schultze-Lutter et al., 
2014), and the association between them and psychiatric disorders strengthens (Kelleher 
et al., 2012). Further, among adults there is a negative correlation between age and 
number of psychotic-like experiences reported (Rietdijk et al., 2014). The gender 
differences in reporting psychotic-like experiences have been controversial. Females 
have reported more psychotic-like experiences than males among adult psychiatric 
patients (Rietdijk et al., 2014) and adolescents in the community (Yung et al., 2009), 
whereas in a few other population studies, the prevalence was higher in males (Kelleher 
et al., 2012; van Os et al., 2009).  
 
1.3 Psychosis risk and predictors of psychosis 
Psychotic-like symptoms are usually transitory and disappear over time (Simon et al., 
2009; van Os et al., 2009; Ziermans, Schothorst, Sprong, & van Engeland, 2011). 
Subclinical psychotic symptoms that are persistent (Dominguez, Wichers, Lieb, 
Wittchen, & van Os, 2011) or linked to negative symptoms and poor global functioning 
(Addington & Heinssen, 2012) are more likely to be predictive of later psychosis. In a 
meta-analysis of prospective population-based studies, psychotic-like experiences in 
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non-help-seeking healthy people were predictive of a 3.5 times higher risk of transition 
to psychosis, and there was a dose-response relation between severity and persistence of 
psychotic-like experiences and conversion to psychosis (Kaymaz et al., 2012). 
Psychotic-like experiences are not only specifically linked to psychosis but are also 
common among non-psychotic disorders (Gaudiano & Zimmerman, 2013; Rietdijk et al., 
2014). In a study conducted in Italy, practically all (98%) help-seeking adolescents 
reported at least one attenuated psychotic-like experience in the Prodromal 
Questionnaire (Brandizzi et al., 2014). In the population, psychotic-like symptoms are 
associated with an increased risk for the development of other mental disorders, help-
seeking and psychiatric hospitalizations (Fisher et al., 2013; Murphy, Shevlin, Houston, 
& Adamson, 2012; Rössler et al., 2011; Werbeloff et al., 2012), even when they had 
been considered to be false-positive ratings (van Nierop et al., 2012). In other words, 
psychotic-like experiences are clinically relevant as they are associated with various 
forms of mental disorder and distress. 
The unspecificity of the symptoms of the prodromal period makes it difficult to 
separate psychosis from depression in the early course of illness (Häfner, an der Heiden, 
& Maurer, 2008; Häfner et al., 2005; Simon, Ferrero, & Merlo, 2001). They both have 
the same kind of early prodromal phase and depressed mood is one of the most common 
first symptoms of the psychosis prodrome. Comorbidity of positive symptoms, with 
anxiety and depression, has been found among risk patients in several studies (Fusar-
Poli, Nelson, Valmaggia, Yung, & McGuire, 2014; Salokangas et al., 2012). Psychotic-
like symptoms co-occurring with anxiety and depression can be a sign of illness severity 
and poorer treatment prognosis (Krabbendam et al., 2005; Wigman et al., 2012). The 
psychosis prodrome can also reflect other diagnoses, indicated by findings of non-
psychotic diagnoses being predictive of later schizophrenia in longitudinal cohort 
studies in Sweden and Denmark (Lewis, David, Malmberg, & Allebeck, 2000; Maibing 
et al., 2014). 
Besides the symptomatic risk approach, the genetic risk approach emphasizes a 
heightened risk for psychosis in cases of a family history of psychosis (Cannon, 2005). 
One of the strongest single indicators of individual schizophrenia risk is a family history 
of schizophrenia (Sørensen et al., 2014). In a large Danish cohort study, the relative risk 
of schizophrenia for persons with a mother with schizophrenia was 9 compared with 
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persons with a mother without the disease (Mortensen et al., 1999). Relative risks for 
persons with an affected father or sibling were 7 (Mortensen et al., 1999). Another 
Danish cohort study reported a 27% risk (relative risk 32) for schizophrenia when a 
person had two affected parents and a 7% risk (relative risk 8) with one affected parent, 
compared to a 1% risk when neither parent had been treated for schizophrenia 
(Gottesman, Laursen, Bertelsen, & Mortensen, 2010). Other psychiatric disorders of 
first-degree relatives also increase the risk of schizophrenia (Mortensen, Pedersen, & 
Pedersen, 2010). A meta-analysis of twin studies estimated the heritability of 
schizophrenia at 81%, meaning that 81% of the variation in liability to schizophrenia is 
due to genetic factors (Sullivan, Kendler, & Neale, 2003).  
Subtle neuroanatomical abnormalities have also been found to predict psychosis. 
They can be studied with various brain imaging techniques, most often with magnetic 
resonance imaging (MRI) of the brain (Cannon, 2005). Several neuroanatomical 
abnormalities are associated with both cognitive deficits and functional outcome in 
psychosis risk patients (Niendam, Jalbrzikowski, & Bearden, 2009). In a recent study, 
MRI-based predictors provided a 36% increase of prognostic certainty among high-risk 
persons recruited at two early recognition centers (Koutsouleris et al., 2014).  
There are also certain developmental and environmental variables associated with 
vulnerability to develop subpsychotic symptoms or a psychotic disorder, such as family 
background and early experiences. Involvement in bullying and family adversity 
predicted psychotic-like symptoms in a population sample (Singh, Winsper, Wolke, & 
Bryson, 2014). In another study, being a victim of bullying was associated with 
psychotic-like symptoms in unaffected controls (Trotta et al., 2013). Comparing 
psychosis cases and controls, bullying victimization was reported twice as likely among 
those with psychosis (Trotta et al., 2013).  
Further, an association between childhood trauma and psychosis has been suggested 
(Bebbington et al., 2004). The prevalence of history of trauma in a psychosis risk 
population is high (Bechdolf et al., 2010) and childhood sexual abuse has been found to 
be one contributing factor in conversion to psychosis (Thompson et al., 2014). Overall, 
according to a meta-analysis, childhood adversities seem to be associated with a high 
risk of psychosis (Varese et al., 2012) and the risk is higher with more violent traumatic 
experiences (Cutajar et al., 2010).  
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Table 3 presents risk factors of schizophrenia based on a meta-analysis by Clarke, 
Kelleher, Clancy, and Cannon (2012). However, the risk factors overlap and may 
interact with each other (e.g. the gene-environment interaction), making it challenging 
to assess the risks separately (Clarke et al., 2012).  
The stress vulnerability model of psychosis emphasizes heightened genetic and/or 
developmental predisposing risk factors, and in addition, triggering events, such as 
stress or substance use, at the onset of the disease (Schizophrenia: Current Care 
Guidelines). In addition to this traditional model, Howes and Murray (2014) have 
recently suggested in their review that the excessively sensitive dopamine system in 
schizophrenia is associated with cognitive misinterpretations, such as paranoid thoughts 
and viewing internal stimuli as externally driven. Psychosis patients show increased 
sensitivity to stress and a greater dopamine release as a response to stress. Negative life 
events affect both the dopamine system and cognitive schema, maintaining a vicious 
cycle of dopamine dysfunction and stress (Howes & Murray, 2014).  
 
Table 3. Risk factors of schizophrenia based on Clarke and colleagues (2012) 
Risk factor Specific risks 
Obstetric complications Complications of pregnancy, abnormal fetal growth and development, 
complications of delivery 
Prenatal infection Prenatal exposure to influenza, herpes, polio, rubella, or toxoplasmosis 
Prenatal stress Exposure to catastrophic events or loss of spouse or relative during 
pregnancy; unwanted pregnancy 
Prenatal nutrition Exposure to famine during pregnancy; deficiency in folate, vitamin D, 
iron, protein during pregnancy 
Childhood trauma Exposure to abuse or domestic violence; involvement in bullying 
Cannabis use Amount used and duration of use, strength of cannabis used 
Epilepsy Epilepsy; family history of epilepsy 
Head injury Traumatic brain injury 
Encephalitis Anti-NMDA receptor encephalitis 
Genetic risk Common low-risk and rare high-risk variants 
 
1.3.1 Detecting psychosis risk 
Various symptom criteria have been developed for detecting a psychosis risk state, with 
a high probability for later psychosis (Addington & Heinssen, 2012; Correll, Hauser, 
Auther, & Cornblatt, 2010; Olsen & Rosenbaum, 2006b), particularly schizophrenia 
(Fusar-Poli, Bechdolf et al., 2013). Table 4 summarizes the most widely used criteria in 
 23 
 
assessing the risk phase of psychosis, although a recent review listed a total of 22 
instruments for assessing psychosis risk (Daneault, Stip, & Refer-O-Scope Group, 
2013). The evaluation tools are also being combined for more efficient identification of 
risk patients (Daneault et al., 2013). The different definitions and operationalizations of 
the risk criteria between research centers can make comparisons of the results difficult 
(Schultze-Lutter, Schimmelmann, Ruhrmann, & Michel, 2013), and the validity of the 
psychosis threshold in psychosis risk research has also been questioned (Yung, Nelson, 
Thompson, & Wood, 2010a).  
Following a lively debate (Shrivastava et al., 2011; Yung, Nelson, Thompson, & 
Wood, 2010b; Yung & Nelson, 2013), Attenuated Psychosis Syndrome (APS) was 
defined in DSM-5 under “Other specified schizophrenia spectrum and other psychotic 
disorders”. APS includes distressing and disabling attenuated hallucinations, delusions, 
or disorganized speech, with a frequency of at least once a week, not better explained by 
another disorder, with symptoms having begun or worsened during the last year  
(Tsuang et al., 2013). The onset/worsening criterion has been criticized, as the idea of 
the APS originally was to pay attention to the attenuated symptoms themselves, not 
xxxx 
Table 4. The most widely used criteria in assessing psychosis risk 
Approach 
Diagnostic 
interview / 
rating system 
Reference 
Ultra High-Risk (UHR) state /  
At-Risk Mental States (ARMS) 
CAARMS Yung & McGorry, PACE clinic, Melbourne, 
Australia (Yung et al., 2005; Yung et al., 2006) 
Prodromal syndromes, 
Clinical High-Risk (CHR) 
SIPS/COPS McGlashan & Miller, Prime clinic, New Haven, 
USA (Miller et al., 1999; Miller et al., 2003) 
Basic symptoms BSABS, SPI-A Huber, Klosterkötter & Schultze-Lutter, Cologne 
Early Recognition project, Germany 
(Klosterkötter, Hellmich, Steinmeyer, & 
Schultze-Lutter, 2001; Schultze-Lutter et al., 
2012) 
Basic symptoms + high-risk 
symptoms 
ERIraos Häfner & Maurer, German Research Network on 
Schizophrenia (Häfner et al., 2004) 
CHR− and CHR+  CASIS Lencz & Cornblatt, RAP, New York, USA 
(Cornblatt et al., 2003; Lencz, Smith, Auther, 
Correll, & Cornblatt, 2004) 
Attenuated Psychosis 
Syndrome (APS) 
DSM-5 (Tsuang et al., 2013) 
CAARMS, Comprehensive Assessment of At-Risk Mental States; PACE, Personal Assessment and Crisis 
Evaluation; SIPS, Structured Interview for Prodromal Syndromes; COPS, Criteria of Prodromal 
Syndromes; BSABS, Bonn Scale for the Assessment of Basic Symptoms; SPI-A, Schizophrenia 
Proneness Instrument, Adult version; ERIraos, Early Recognition Inventory; RAP, Recognition and 
Prevention; DSM-5, Diagnostic and Statistical Manual of Mental Disorders, 5th edition 
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only with respect to possible progression to psychosis. A criterion “not always having 
been present in its current severity” has been proposed instead, thus differentiating APS 
symptoms from trait-like symptoms (Schultze-Lutter et al., 2014). There is encouraging 
data on the reliability and validity of the APS, and currently it is stressed that multiple 
shifts from APS are possible; the outcomes ranging from psychosis to depression and 
other non-psychotic disorders, or spontaneous remission (Fusar-Poli, Carpenter, Woods, 
& McGlashan, 2014). 
Three risk groups can be separated using the symptomatic risk approach: patients 
with Attenuated Psychosis Syndrome (APS) symptoms, patients who present symptoms 
at the psychotic level of intensity for a short time, less than a week (Brief Limited 
Intermittent Psychotic Symptoms, BLIPS), and patients with lowered functioning in 
addition to schizotypal personality or familial risk to psychosis (Genetic Risk and 
Deterioration syndrome, GRD). The biggest risk to psychosis appears to be associated 
with the BLIPS state, and this group is considered to represent the later phase of the 
prodrome, while individuals with GRD are considered to be at an early phase of the 
prodrome with a lower risk to transition compared with the other risk groups (Nelson, 
Yuen, & Yung, 2011). 
 
1.3.1.1 CAARMS and SIPS interviews 
Of the structured interviews developed for the identification of the above-mentioned 
psychosis risk states, the Comprehensive Assessment of At-Risk Mental States or 
CAARMS (Yung et al., 2006) was the pioneer. The criteria for the ultra high-risk 
(UHR) groups were operationalized in Australia using two interview methods, the Brief 
Psychiatric Rating Scale (BPRS) and the Comprehensive Assessment of Symptoms and 
History (CASH), to create a new instrument. Yung and McGorry also created a 
definition of frank psychosis used as the outcome measure: presence of clear threshold 
level psychotic symptoms occurring several times per week for at least a week. The risk 
criteria were then tested at the PACE clinic with an encouraging 12-month transition 
rate of over 40% (Yung et al., 2006). These risk criteria have been adopted and adapted 
internationally. 
Besides the CAARMS, one of the most widely used interviews is the Structured 
Interview for Prodromal Syndromes, SIPS (Miller et al., 2003). The Clinical High-Risk 
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(CHR) approach, developed in the United States, is most often used in North America, 
while the UHR is used in Europe and Australia (Correll et al., 2010). However, the 
differences between the two high-risk approaches are scarce and both divide risk groups 
similarly (Miller et al., 2003). In the SIPS interview, psychotic-like and other risk 
symptoms are also mapped and criteria for prodromal syndromes are evaluated. For 
every symptom reported by the patient there are additional qualifiers to inquire into, 
including the degree of conviction, degree of distress, and degree to which the symptom 
interferes with daily life. Psychosis is defined by one or more of the positive symptoms 
scored at 6, a psychotic level of intensity, with a frequency of at least four days a week 
and duration of at least a month, or being a seriously disorganizing or dangerous 
symptom (Miller et al., 2003).  
The prodromal risk syndrome detected by the SIPS has been suggested as a valid 
diagnostic entity, distinct from other psychiatric disorders (Woods et al., 2009). There is 
a definite need for care with persons fulfilling the risk criteria, as they present more 
severe symptoms and low functioning than people with established psychosis who 
already receive treatment (Woods et al., 2009). Psychosis risk status is also associated 
with long-term impairment in both social and role functioning (Addington et al., 2011) 
and disruptive symptoms, also found among those who do not develop psychosis during 
follow-up, in other words, false-positive risk individuals (Haroun, Dunn, Haroun, & 
Cadenhead, 2006). 
Since the early years of psychosis risk research, a reduction in the psychosis 
transition rate has been noticed, with false positives lately outnumbering true positives 
(Yung et al., 2007; Yung et al., 2008). In a long-term follow-up, including studies 
between 1993 and 2006, it was found that risk patients recruited in the earlier years had 
a significantly higher transition rate than later cohorts (Nelson et al., 2013). This is 
consistent with significant transition rate reductions over time also found by other study 
groups (Fusar-Poli, Bonoldi et al., 2012; Simon et al., 2011). Possible reasons may be 
the better detection and treatment of risk patients (Cannon, Cornblatt, & McGorry, 
2007; Simon et al., 2011). Since risk patients are identified early in the process, the 
transition can also take longer than previously. Hence, a long follow-up time of the risk 
individuals has been recommended by several researchers (Fusar-Poli, Bonoldi et al., 
2012; Riecher-Rössler et al., 2009).  
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Still, with alternative methods to define the risk state, the psychosis risk state is 
associated with a 36% risk for psychosis during a three-year follow-up according to a 
meta-analysis (Fusar-Poli, Bonoldi et al., 2012). Similarly, in a review by Gee and 
Cannon (2011), it was approximated that about 1/3 of psychosis risk cases convert to 
psychosis, about 1/3 do not convert but remain symptomatic and functionally impaired, 
and about 1/3 recover symptomatically and functionally. According to their results, 
recovery from the risk status may be predicted by higher social functioning and lower 
rating of negative symptoms at baseline (Gee & Cannon, 2011).  
1.3.1.2 Other approaches 
Psychosis has also been predicted with basic symptoms, which are subtle, self-
experienced anomalies (Klosterkötter et al., 2001). These include cognitive experiences 
(such as thought blockages), perceptual experiences (for example sensitivity to light), 
motor experiences (such as loss of automatic skills), and bodily experiences (such as 
electric sensations, pain, numbness, and sensations of abnormal heaviness or lightness). 
Not only positive symptoms are important when predicting psychosis and 
concentrating solely on them may lead to false positives and false negatives, that is, 
missing some of the real at-risk patients (Simon & Umbricht, 2010). Various baseline 
variables besides positive symptoms have been found to be effective in predicting 
psychosis (Mees et al., 2011). For instance, impaired social and role functioning have 
been found to predict clinical outcome and psychosis in CHR patients (Cornblatt et al., 
2012; Fusar-Poli et al., 2010).  
Furthermore, negative symptoms have also been found to predict transition to 
psychosis along with or even better than positive, psychotic-like symptoms (Demjaha, 
Valmaggia, Stahl, Byrne, & McGuire, 2012; Mason et al., 2004; Piskulic et al., 2012; 
Schlosser et al., 2012; Velthorst et al., 2009). The RAP study group in New York 
differentiates CHR− and CHR+ risk groups, the former characterized by negative and 
non-specific symptoms, representing the early prodrome stage, and the latter 
characterized by attenuated positive symptoms, closer to established psychosis 
(Cornblatt et al., 2003; Cornblatt, 2002; Lencz et al., 2004). In this approach, attention 
is given to cognitive deficits, affective disturbances, social isolation, and school 
functioning, referred to as the CASIS cluster (Cornblatt et al., 2012).  
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In NAPLS, which is a large multisite longitudinal study in North America, five 
features were used as psychosis predictors: genetic risk with decrease in functioning, 
low social functioning, substance abuse, and the two positive symptom scales of 
unusual thought content and suspiciousness (Cannon et al., 2008). With these variables 
used in prediction algorithms, the positive predictive power was higher than with using 
the psychosis risk status alone. Some studies have used total SIPS symptom scores and 
highest single-item positive symptom scores to predict psychosis, instead of the CHR 
state (Lencz, Smith, Auther, Correll, & Cornblatt, 2003). In a long follow-up of risk 
patients, the best predictive value was accomplished by weighting suspiciousness, social 
anhedonia, and reduced cognitive speed (Riecher-Rössler et al., 2009). In another study, 
disorganized communication was the best predictor of transition to psychosis during a 
2.5-year follow-up (DeVylder et al., 2014). Based on a large European multi-center 
study, using a two-step risk assessment, a risk group can first be assembled with the use 
of SIPS and basic symptoms, and then the risk of transition can be evaluated for each 
individual using the formula of a prediction model consisting of positive symptom, 
bizarre thinking, and sleep disturbance scores; schizotypia, highest level of functioning 
during the past year, and years of education (Ruhrmann et al., 2010). To summarize, 
along with the psychosis risk status, various combinations of symptoms have been 
found to be predictive of psychosis. Final consensus is still to be reached, as the 
significant predictors vary greatly across studies, with one possible cause being 
differences in participant recruitment. 
1.3.1.3 Questionnaires 
As interviews such as the SIPS are time consuming and require special training, 
questionnaires focusing on the early detection of psychoses have been developed 
(Daneault et al., 2013; Olsen & Rosenbaum, 2006a). The most widely used screening 
instruments are the PROD-screen (Heinimaa et al., 2003), the PRIME-screen (Miller, 
Chicchetti, Markovich, McGlashan, & Woods, 2004), the Youth Psychosis at-Risk 
Questionnaire (Kline et al., 2012; Ord, Myles-Worsley, Blailes, & Ngiralmau, 2004), 
and the Prodromal Questionnaire (Loewy, Bearden, Johnson, Raine, & Cannon, 2005). 
The questionnaires assessing psychotic-like experiences have been found to have good 
structural and criterion validity (Therman, 2014). 
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Screeners are validated against gold standard measures such as the SIPS or the 
CAARMS (Kline & Schiffman, 2014). Screening instruments are also used to estimate 
symptom prevalence and to screen for psychotic symptoms to select likely high-risk 
patients for targeted interviews. Using a two-step screening and interview procedure, 
CHR prevalence seems to be at 4–5% among unselected help-seeking adolescent and 
young adult samples (Kline & Schiffman, 2014). Comparing different recruitment 
strategies in psychosis risk studies, it has been found that screening reduces the number 
of false positives (Rietdijk et al., 2012); the increased likelihood ratio for psychosis 
among screen-positives has been estimated to range from 1.5 to 3.8 (Gale, Glue, & 
Gallagher, 2013).  
1.3.1.4 Detecting psychosis risk in different samples 
As the risk criteria have been developed for help-seeking individuals, psychosis risk 
detection in the general population does not seem advisable, the main problem being 
high rate of false positives. For example, in the general population-based Northern 
Finland Cohort 1986, the symptomatic risk group consisted of participants with 
functional impairment and attenuated positive symptoms reported in questionnaires. 
Only 5% fulfilled the psychosis risk criteria of the SIPS (Veijola et al., 2013).  
It has been suggested that the choice of the study population has a significant impact 
on the ability of the CHR status to predict later psychosis (Yung et al., 2008). Current 
psychosis risk criteria have mostly been studied with highly selected patient samples in 
clinics specialized in treating patients with a psychosis risk (Fusar-Poli, Yung, McGorry, 
& van Os, 2014). These clinics use screening methods to enrich the patient samples, and 
referral to the clinic may be based on the referring clinician’s impression of heightened 
psychosis risk (Addington et al., 2012; Broome et al., 2005; Cannon et al., 2008; 
Ruhrmann et al., 2010). As expected, the proportion of the patients who develop 
psychosis is high in such preselected high-risk research. Although psychosis risk 
defined with the current criteria predicts psychosis among those who seek help for 
psychosis risk symptoms (Loewy, Therman, Manninen, Huttunen, & Cannon, 2012), it 
is unclear if the results can be generalized to all psychiatric patients who seek help for 
various other symptoms (Fusar-Poli, Borgwardt et al., 2013).  
Yung et al. (2006) found conversion to be low in a sample of help-seeking young 
people of which 41% were considered to be at risk for psychosis. Within 6 months, 10% 
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of the UHR patients became psychotic, the sensitivity and specificity of the risk status 
being 92% and 62%, respectively (Yung et al., 2006). Otherwise, the usability of the 
internationally used psychosis risk criteria and methods in an unselected sample of 
adolescent psychiatric patients has been largely unaddressed. It could be hypothesized 
that the CHR state also predicts psychosis among unselected psychiatric help-seekers, 
but with a weaker predictive value than in studies made in specialized clinics.  
 
1.4 Other outcomes besides psychosis in psychosis risk 
In psychosis risk studies, conversion to psychosis is not the only relevant outcome 
(Fusar-Poli, Borgwardt et al., 2013). It has even been envisioned that the high-risk state 
could more broadly be a general syndrome of early mental distress, with a heightened 
risk for a range of mental disorders; not just psychosis but, for instance, for mood 
disorders (Fusar-Poli, Yung et al., 2014). Soft entry for treatment of risk symptoms, 
regardless of diagnosis, and matching illness stage to intervention have also been 
proposed, and is referred to as the clinical staging model (Cross et al., 2014; McGorry & 
van Os, 2013; McGorry et al., 2014).  
The major criticism of psychosis risk studies has been that a severe decline in 
functioning and negative symptoms can remain neglected if the positive symptoms of 
the person do not reach the limit of transition to psychosis (Broome & Fusar-Poli, 2012). 
Many studies have recently included functioning as an outcome of interest in itself 
(Cotter et al., 2014; Salokangas et al., 2013), reflecting the everyday ability to perform 
and quality of life better than a diagnosis number. In a review, baseline negative and 
disorganization symptoms predicted poor functioning during follow-up, whereas 
positive symptoms did not (Cotter et al., 2014). 
 
1.5 Psychosis and cognition 
1.5.1 Cognition and the assessment of cognition 
Cognition means information processing, including various mental processes starting 
from perception of sensory input and attention to more complex processes of 
interpretation, memory, reasoning, problem solving, decision making, and language. 
 30 
 
Within each class of cognitive functions, a division can be made between verbal and 
non-verbal functions (Lezak, Howieson, Bigler, & Tranel, 2012).  
Cognitive assessment means evaluating these processes. The purposes of such 
assessment vary from aid in making a diagnosis, planning treatment and rehabilitation, 
and evaluating the effectiveness of treatment and level of functioning, to providing 
information for a legal matter, or doing research (Lezak et al., 2012). Taking the client’s 
background, history and circumstances into consideration, the examiner uses 
observation, interview, and a selection of tests designed to examine cognitive 
functioning (Lezak et al., 2012). Neuropsychological tests are used to measure attention, 
reasoning, memory, speed, visuomotor functions, and visual and verbal functions, and 
the results are compared to population norms where the age of the person is taken into 
account. Cognition related to psychiatric disorders can be assessed using various 
instruments (Bakkour et al., 2014). 
1.5.2 Cognitive deficits in psychosis 
Psychotic disorders are associated with significant cognitive impairments to the extent 
that schizophrenia can be seen as a disorder of information processing (Hambrecht, 
Lammertink, Klosterkötter, Matuschek, & Pukrop, 2002). A recent review showed that 
compared to healthy controls, global cognitive impairment was already present in first-
episode psychosis patients, the largest effect sizes being observed for verbal memory, 
executive function, and general IQ (Aas et al., 2014). Compared to schizophrenia, 
cognitive deficits appear to be slightly less severe but present in affective psychoses and 
schizoaffective disorder (Bora, Yucel, & Pantelis, 2009; Heinrichs, Ammari, McDermid 
Vaz, & Miles, 2008; Trotta, Murray, & MacCabe, 2014).  
In the course of the psychotic illness, the cognitive deficits tend to stay preserved and 
not respond to changes in the clinical state or medication (Cornblatt, Obuchowski, 
Schnur, & O'Brien, 1997). Cognitive deficits can also be found among antipsychotic-
naïve psychosis patients (Fatouros-Bergman, Cervenka, Flyckt, Edman, & Farde, 2014; 
Saykin et al., 1994). 
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1.5.3 Cognition and psychosis risk 
Cognitive impairment is already present in the premorbid and prodromal phases of the 
psychotic illness (Bora et al., 2014; Erlenmeyer-Kimling et al., 2000; Fusar-Poli, Deste 
et al., 2012; Hambrecht et al., 2002; Klosterkötter, Schultze-Lutter, Gross, Huber, & 
Steinmeyer, 1997; Trotta et al., 2014), suggesting that at least some of these deficits are 
primary and not secondary to the psychotic symptoms. In a large cross-sectional study, 
the neurocognitive function of those children and adolescents endorsing psychotic 
symptoms was behind in chronological age compared with typically developing youths, 
with greater developmental delay among those with more significant symptoms (Gur et 
al., 2014).  
A meta-analysis showed that individuals with subsequent schizophrenia had lower 
IQ at the age of 13 and impaired motor functioning at the age of 16, but there were no 
differences in their general academic and mathematical achievement compared to those 
who did not develop the disease (Dickson, Laurens, Cullen, & Hodgins, 2012).  
The cognitive problems of psychosis risk patients are qualitatively similar but milder 
than in psychosis, performance being at a level intermediate to that displayed by first-
episode psychosis and control samples (Keefe et al., 2006). Individuals who fulfill 
criteria for psychosis risk seem to have deficits especially in processing speed and 
verbal memory (Gschwandtner et al., 2003; Kelleher et al., 2013; Michel, Ruhrmann, 
Schimmelmann, Klosterkötter, & Schultze-Lutter, 2014; Seidman et al., 2010). 
However, neuropsychological impairments have not been been evident in all studies, 
such as in a non-help-seeking high-risk sample drawn from the Northern Finland 1986 
birth cohort (Mukkala et al., 2011). Lower cognitive performance is associated with 
more severe depressive sympoms in psychosis risk patients, emphasizing the 
significance of the neurocognitive challenges (Ohmuro et al., 2015). 
1.5.4 Predicting psychosis and functioning with cognition 
In studies of cognition and later psychosis, various predictors of transition to psychosis 
have been found. Visuospatial performance has been found to predict psychosis among 
risk patients (Brewer et al., 2005; Wood et al., 2003) and among Finnish male 
conscripts (Tiihonen et al., 2005). Later conversion to psychosis has also been found to 
be associated with verbal deficits, especially weaker verbal memory (Fusar-Poli, Deste 
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et al., 2012; Valli, Tognin, Fusar-Poli, & Mechelli, 2012), although not all studies have 
found such an association (Tiihonen et al., 2005). More rapid conversion to psychosis 
was predicted by verbal memory deficits in one study (Seidman et al., 2010). 
Many longitudinal studies have found childhood cognitive performance to predict 
psychosis. A higher risk of adult schizophrenia seems to be connected to lower verbal 
and non-verbal childhood cognitive functioning (Cannon et al., 2000; MacCabe, 2008). 
In several longitudinal studies, cognitive overall performance has been found to be 
weaker than average among those who later develop a psychotic disorder (Erlenmeyer-
Kimling et al., 2000; Jones, Rodgers, Murray, & Marmot, 1994; Koenen et al., 2009) 
and among those risk patients who later convert to psychosis compared to those do not 
convert (Keefe et al., 2006; Niemi, Suvisaari, Tuulio-Henriksson, & Lönnqvist, 2003). 
Cognitive decline seems to be relatively specific to schizophrenia, as compared to, for 
instance, individuals with persistent depression (Meier et al., 2014). Further, high 
intellectual capacity has been found to be a protective factor against psychosis 
(Davidson et al., 1999). Interestingly, high cognitive performance has been associated 
with a heightened risk for bipolar disorder and mania (Koenen et al., 2009; MacCabe et 
al., 2013; Tiihonen et al., 2005), and in the Northern Finland 1966 birth cohort study, 
superior school performance was also a risk factor for schizophrenia in males (Isohanni 
et al., 2006). 
In a longitudinal cohort study, a decline in cognitive performance in adolescence and 
young adulthood, particularly in verbal ability, was associated with an increased risk for 
psychosis in adulthood (MacCabe et al., 2013). In another study, adult psychotic 
symptoms were best explained by an IQ decline during early childhood (Kremen et al., 
1998). Progressive cognitive impairments (Woodberry et al., 2013) or lack of cognitive 
improvement in follow-up testing (Keefe et al., 2006) have also been found to 
accompany risk for psychosis. Among psychosis risk patients, recently emerging or 
intensifying cognitive deficits were to some extent predictive of transition (Hambrecht 
et al., 2002). In a meta-analysis among high-risk participants, later transition to 
psychosis was associated with more severe cognitive deficits in all domains except 
sustained attention (Bora et al., 2014). These results imply that cognitive dysfunction 
may be a likely neurobiological marker of psychosis and specifically, a core feature of 
schizophrenia vulnerability (Cannon et al., 2000; McGorry et al., 2014). However, it has 
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been noted in several studies that cognitive impairment by itself has a limited capacity 
to actually predict the outcome of high-risk patients (Bora et al., 2014; Valli et al., 
2012).  
Irrespective of psychosis transition, cognitive deficits affect everyday functioning. 
When functional capacity has been used as an alternative outcome, cognitive deficits 
have predicted impaired functioning during follow-up among psychosis risk patients 
(Cotter et al., 2014). Lin et al. (2011) showed larger and broader differences in cognitive 
performance when comparing psychosis risk individuals with poor or good functional 
outcome, than when comparing those with and without transition to psychosis. Lowered 
performance on logical memory at baseline was the strongest predictor of poor 
functional outcome (Lin et al., 2011). In another study, baseline cognitive functioning 
was not associated with psychosocial outcome but the course of neurocognitive change 
during follow-up differentiated patients with good and poor functional outcomes 
(Niendam et al., 2007). 
1.5.5 Cognition and symptoms domains 
Across the psychosis continuum, different psychosis symptoms can be associated with 
different cognitive abnormalities. Cognitive dysfunction seems to have little or no 
association with positive symptoms among schizophrenia patients (Cameron et al., 2002; 
Lucas et al., 2004; O'Leary et al., 2000; Rhinewine et al., 2005; Strauss, Buchanan, & 
Hale, 1993; Van der Does, Dingemans, Linszen, Nugter, & Scholte, 1993) or psychosis 
risk patients (Niendam et al., 2006; Ohmuro et al., 2015), although some studies have 
discovered that positive symptoms may be linked to slower information processing 
speed in the general population (Simons, Jacobs, Jolles, van Os, & Krabbendam, 2007) 
or poorer verbal fluency in psychosis patients (Verdoux et al., 1999). In one study 
conducted among schizophrenia patients, positive symptoms were associated with 
memory and attention impairment (Talreja, Shah, & Kataria, 2013). One possible 
explanation for this may be symptoms occurring during the testing, leading to an 
inability to concentrate (Strauss, 2011). 
Compared to positive symptoms, negative symptoms seem to have a stronger 
connection to cognitive deficits (Bilder et al., 2000; Ventura, Hellemann, Thames, 
Koellner, & Nuechterlein, 2009). The association between negative symptoms and both 
 34 
 
processing speed (Cameron et al., 2002; Cuesta & Peralta, 1995; O'Leary et al., 2000; 
Rhinewine et al., 2005) and verbal performance (Dominguez, Viechtbauer, Simons, van 
Os, & Krabbendam, 2009) is well established among patients with psychosis and the 
latter has even been discovered in the general population (Simons et al., 2007), leading 
to speculation that the symptoms and cognition may be expressions of the same 
phenomenon, possibly a cerebral connectivity impairment (Dominguez et al., 2009). 
However, not all studies have found any connection between negative symptoms and 
cognitive deficits among psychosis patients (Cornblatt et al., 1997; Joyce et al., 2002; 
Lucas et al., 2004; Verdoux et al., 1999) or psychosis risk patients (Niendam et al., 
2006). 
The association between cognitive performance and psychosis risk symptoms needs 
further research. Specifically, the issue of cognitive deficits among adolescents referred 
to general psychiatric care, comprising non-selected help-seeking adolescents with and 
without psychosis risk symptoms, is an interesting area of research. By finding which 
areas of cognitive performance are linked to more severe psychosis risk symptoms, 
clinical attention can be targeted accordingly in adolescent psychiatric care. 
 
1.6 Intentional self-harm 
Intentional self-harm refers to for example poisoning or injury of bodily tissues. A 
dichotomous separation can be made between non-suicidal and suicidal self-injury, 
although the intent of self-harm is not always clear (Hasley et al., 2008). In a study 
among adolescents presenting with self-harm, cutting was usually coded as non-suicidal 
self-harm, and suicidal self-harm appeared to start at an older age, with poisoning as a 
common mean (Ougrin et al., 2012). Among suicide attempters admitted to medical 
wards in Norway, adolescents with intent to die had more serious suicide attempts and 
reported more severe depressive and other symptoms compared to those without such 
intention (Grøholt, Ekeberg, & Haldorsen, 2000). The authors also stated, however, that 
the need for help in the group with no intent to die may be underestimated (Grøholt et 
al., 2000). 
Suicidality can be seen as a continuum ranging in severity from recurrent thoughts of 
death and suicidal ideation to suicide plans, attempts, and finally completed suicide. In a 
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large adolescent population sample it was found that one third of suicide ideators will 
make a suicide plan, about 60% of those with a plan will attempt suicide, and that these 
transitions between stages of suicidality usually happen during the first year of onset of 
ideation (Nock et al., 2013). In another study, suicidal ideation at age 15 years was 
associated with long-term emotional and behavioral difficulties and was a risk marker of 
suicide attempts at age 18 years (Reinherz et al., 1995).  
While adolescents with any behavior within the suicidal spectrum are at a high risk 
of making a suicide attempt, it has to be noted that suicidal ideation, having thoughts 
about ending one’s life, is common in this age group (Pearce & Martin, 1994). In the 
United States, 12% of adolescents between 13–18 years of age reported lifetime suicidal 
ideation (Nock et al., 2013). Among Australian school students the lifetime prevalence 
of suicidal ideation was 31% and current prevalence 16% (Delfabbro, Winefield, & 
Winefield, 2013). Girls had more suicidal ideation than boys, and other significant 
predictors included substance use and psychological distress (Delfabbro et al., 2013).  
According to a review of self-harm in adolescents in the population, around 10% 
reported having self-harmed (Hawton, Saunders, & O'Connor, 2012). Psychiatric 
disorders, alcohol abuse, and smoking were associated with suicidality (Hawton et al., 
2012). Lifetime suicide attempts were reported by 4% of adolescents in the United 
States (Nock et al., 2013).  
Self-harm is a major health concern particularly among adolescents with psychiatric 
disorders. In a Finnish longitudinal study of adolescent psychiatric outpatients with 
major depressive disorder, 22% had a history of suicide attempt at baseline, 14% 
attempted suicide during 1-year follow-up, and 12% during follow-up from 1 to 8 years 
(Tuisku et al., 2014). In a sample of adolescent psychiatric inpatients aged 12–17 years, 
13% of the boys and 26% of the girls had attempted suicide during their lifetime 
(Tikkanen et al., 2009). 
1.6.1 Suicide 
Suicide rates in Finland are high (Official Statistics of Finland (OSF)), and although 
rates of adult suicides have declined, rates of adolescent suicides have not, with the 
prevalence remaining high compared to other European countries (Safety Investigation 
Authority, 2014). Suicide is the most common cause of death among 15–19-year-old 
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boys in Finland. During the years 2009–2011, there were 51 suicides committed by 
children and adolescents under the age of 18 years in the whole country, the youngest to 
commit suicide being 13 years old (Safety Investigation Authority, 2014). A third of the 
adolescents who had committed suicide were under the influence of alcohol and the 
most common way to commit suicide was to jump under a train.  
Three-quarters of adolescent suicides during the years 2009–2011 were committed 
by boys (Safety Investigation Authority, 2014). The male-to-female ratio was 3.6:1 in a 
study investigating all 901 suicides committed by persons under the age of 18 years 
during the years 1969–2008 (Lahti, Räsänen, Riala, Keränen, & Hakko, 2011). The 
study group noticed that whereas the rate of male adolescent suicides in Finland has 
decreased since 1990, the rate of female adolescent suicides has increased, and that 
violent, more lethal suicide methods have become more common among females (Lahti 
et al., 2011).  
The so-called gender paradox means that while suicidal ideation and suicide attempts 
are more common among females than males, of the completed suicides the majority are 
committed by males (Delfabbro et al., 2013; Hawton et al., 2012; Qin, Agerbo, 
Westergard-Nielsen, Eriksson, & Mortensen, 2000; Schrijvers, Bollen, & Sabbe, 2012). 
Not all studies have found these differences, however, such as Suokas and colleagues in 
a study of suicide attempts among young Finnish adults (2011). Possible reasons for the 
gender paradox are various (Schrijvers et al., 2012). For instance there can be cultural 
factors in reporting suicidality, men use more lethal means in suicide attempts than 
women, and women seek help more often than men. Women also tend to rethink more 
often than men and men’s suicidal process is shorter than women’s. 
A stress-diathesis model of the risk factors of suicide has been suggested (Hawton & 
van Heeringen, 2009). The predisposing factors can be related to family environment, 
hopelessness, cognitive styles, or genetic risk, while the triggering factor can be, for 
instance, a life event or a mood disorder (Hawton & van Heeringen, 2009). In the 
Northern Finland 1966 birth cohort study, daily smoking at aged 14, a single parent-
family, and a family with more than five children were risk factors for suicidal behavior 
in the general population (Alaräisänen, 2010). 
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1.6.2 Positive symptoms and self-harm 
Psychotic disorders are associated with a high lifetime risk for suicide (Li, Page, Martin, 
& Taylor, 2011; Pompili et al., 2011; Suokas et al., 2010). According to a systematic 
review and meta-analysis, among mental disorders, schizophrenia is associated with the 
highest relative risk for suicide in men and the third highest in women after substance 
and affective disorders (Li et al., 2011). For example, in the Northern Finland 1966 birth 
cohort followed prospectively until 39 years of age, 7% of schizophrenia patients 
committed suicide, the majority of the suicides taking place during the first three years 
after onset of the illness (Alaräisänen, 2010). In first-episode psychosis and other 
hospitalizations, the suicide rate is highest soon after discharge (Pompili et al., 2011; 
Qin et al., 2000). 
 Contradicting results have been reported concerning the association between positive 
symptom severity in psychosis and suicidality. In a review of schizophrenia and suicide, 
reduced suicide risk was found to be associated with hallucinations (Hawton, Sutton, 
Haw, Sinclair, & Deeks, 2005). In a study made in emergency psychiatric services, 
pseudohallucinations (experienced as coming from within the head) were associated 
with increased suicidality compared to lower suicidality among those with auditory 
hallucinations (experienced as coming from outside the head) or no hallucinations 
(Penagaluri, Walker & El-Mallakh, 2010). In a large sample of schizophrenia patients, 
delusional and hallucination severity and distress were associated with self-harm 
(Haddock, Eisner, Davies, Coupe, & Barrowclough, 2013). Further, in a sample of 
schizophrenia and schizoaffective disorder patients, command auditory hallucinations 
for suicide were somewhat associated with suicide attempts (Harkavy-Friedman et al., 
2003). In a sample of both psychotic and psychosis risk patients assessed with a 
momentary assessment technique of mobile phone-based measures several times a day 
for seven days, psychotic symptoms and especially paranoia seemed to trigger self-
injurious thoughts the next day (Palmier-Claus et al., 2014). Nevertheless, a meta-
analysis of first-episode psychotic patients suggested that positive symptoms are 
unrelated to deliberate self-harm (Challis, Nielssen, Harris, & Large, 2013). 
 Many of the suicide risk factors among psychosis patients, such as depression, 
hopelessness, suspiciousness, social isolation, and substance use, may also be risk 
factors for suicidality among psychosis risk patients (Hutton, Bowe, Parker, & Ford, 
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2011). Self-harm may also serve as a maladaptive coping mechanism from stress and 
negative emotions caused by the confusing positive symptoms (Palmier-Claus et al., 
2014). On the other hand, risk patients may not yet have been exposed to some of the 
factors that may be linked to increased suicide risk in people with established psychosis, 
such as stigma, social exclusion, and trauma of being admitted to hospital (Hutton et al., 
2011). Nevertheless, suicidal ideation has been reported to be high among patients at 
high risk for psychosis (DeVylder et al., 2012; Granö et al., 2013; Hutton et al., 2011; 
Taylor, Hutton, & Wood, 2015). 
 In a study conducted among school children aged 13 to 15 years with psychiatric 
disorder, psychotic-like symptoms were associated with 5-fold increased odds of 
suicidal behavior (Kelleher et al., 2012). In young people aged 12–16 referred to mental 
health services, psychotic experiences were strong markers of risk for suicide plans and 
attempts, highlighting that a report of psychotic experiences in a young person with 
psychopathology should alert clinicians to the risk for suicidal behavior (Kelleher et al., 
2014).  
 Further, among adult psychiatric outpatients, attenuated psychotic symptoms were 
associated with more severe suicidal ideation and suicide attempts (Gaudiano & 
Zimmerman, 2013). In a longitudinal study, childhood psychotic symptoms at age 11 
predicted suicide attempts by age 38 (Fisher et al., 2013). Retrospectively viewed, a 
large number of schizophrenia patients were suicidal in the prodromal phase and 
patients with suicidal behavior experienced a greater number of positive prodromal 
symptoms (Andriopoulos, Ellul, Skokou, & Beratis, 2011). Suicide attempts were 
associated with an earlier onset of prodromal symptoms and frank psychosis 
(Andriopoulos et al., 2011).  
 Psychotic-like experiences have been found to be associated with suicidal ideation 
and behavior even in a general adolescent population (Jang et al., 2014; Kelleher et al., 
2012). Among Japanese school children, especially hearing voices and a feeling of 
being followed increased the risk of suicidal feelings and deliberate self-harm (Nishida 
et al., 2010). In adult populations, delusional-like experiences (Saha et al., 2011) and 
psychotic-like symptoms (Suokas et al., 2011) have also been found to be markers of 
vulnerability to suicide.  
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 The association between suicidality and psychotic-like symptoms in a general 
adolescent psychiatric sample is an area needing further research, with the aim of more 
efficient detection of the risks of self-destructive behavior among young psychiatric 
patients. 
 
1.7 Adolescence and adolescent psychiatric care 
Adolescense is a distinct life stage with specific developmental tasks and challenges, 
beginning with biological changes related to puberty and lasting roughly from the age of 
12 to 22 (Marttunen & Kaltiala-Heino, 2014). The developmental tasks of adolescence 
include forming an adult identity and separation from the childhood home. 
Development is intense in adolescence in many areas; there are physical as well as 
psychosocial changes, and adolescents have to cope with major changes in their bodies 
as well as psychological changes (Turk, Graham, & Verhulst, 2007). The young person 
has a growing need for independence and belonging to a peer group, but at the same 
time, still needs a lot of support from the family. Interest in intimate releationships also 
gradually increases during adolescence. Areas of school work, hobbies, and future plans 
are all psychosocial factors influencing the life of the adolescent person. With 
maturation in brain structure and activity, there are also major cognitive changes during 
the adolescent stage, involving development in abstract thinking and reasoning and 
information processing skills (Paus, Keshavan, & Giedd, 2008). 
In health care, adolescent patients are a specific age group. Answering to a special 
need of this group between childhood and adulthood, adolescent medicine and 
adolescent psychiatry are specific areas of expertise in Finland. In the Act on the Status 
and Rights of Patients, rapid entry to mental health treatment is required for adolescent 
patients, conceptualized as those between 13 and 23 years of age. Both inpatient and 
outpatient units for treating adolescent psychiatric patients are available, the emphasis 
of the care being on outpatient clinics and involving the young person’s social network 
in the treatment process.  
Support of the school health care (e.g., school nurse and psychologist) promotes the 
mental health of students in the adolescents’ daily environment. Trouble at school and  
disconnection from social relationships are warning signs of mental health problems, 
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and staying in school is important for the well-being of the young person (Kaltiala-
Heino, Ranta, & Frojd, 2010). Prompt intervention in school bullying also promotes 
mental health among all those in the school environment (Kaltiala-Heino et al., 2010). 
The prevalence of psychiatric disorders in adolescence doubles when compared to 
childhood, being 15–25% across epidemiological studies (Marttunen & Kaltiala-Heino, 
2014). Many mental disorders still affecting life in adulthood start in adolescence (Paus 
et al., 2008). These include anxiety and mood disorders, eating disorders, and 
substance-related problems. Specifically, depression and social phobia are common 
disorders among adolescents, and often occur in a comorbid fashion, as found for 
example in the prospective Adolescent Mental Health Cohort study in Finland among 
15-year-olds from the population (Väänänen et al., 2011). 
The incidence of psychotic disorders, particularly schizophrenia, also peaks in 
adolescence and early adulthood (Pedersen et al., 2014). Early recognition of symptoms 
and effective interventions may have the greatest impact on the long-term outcome in 
this age group. This is why psychosis risk symptoms are often studied among 
adolescents. 
 
1.8 Motivation of the current study 
Earlier results concerning psychotic-like symptoms cannot be generalized to all 
adolescents seeking help in a general psychiatric setting. In addition, the validity of the 
psychosis risk assessment methods translated into Finnish have not yet been studied. 
The Helsinki Prodromal Study was therefore designed to shed light on psychotic-like 
symptoms and clinical high-risk status in an unselected clinical adolescent population. 
Detecting subclinical positive symptoms, it is often possible to identify an individual as 
having a high risk of psychosis before the onset of the first episode of the disease. 
However, the predictiveness of these psychotic-like symptoms depends on the 
population, and many earlier high-risk studies have been conducted in preselected 
samples with subjects referred to the services because of a suspicion of psychosis risk.  
 In this study, a questionnaire was used to screen for psychosis risk symptoms, and 
the predictive validity of the screen was studied. Another goal was to identify 
adolescents with CHR from patients who sought help from adolescent psychiatric 
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clinics, and to investigate whether CHR status is as predictive of psychotic disorder in 
these services as it is in services specialized for the treatment of psychosis prodrome. 
Performance on specific tests of neurocognition may prove to be early risk predictors 
for psychosis. The association between positive symptoms and a decline in cognitive 
performance can already be seen before the onset of psychosis among persons with an 
increased risk for psychosis. Including measures of cognitive functioning could 
therefore potentially improve the discriminability of the current psychosis risk detection 
criteria. At the moment, the psychosis risk concept does not include cognitive 
deterioration, although some efforts have been made to add cognition to prodromal 
criteria: the importance of negative symptoms and cognitive deficits in schizophrenia 
risk is stressed both in the CASIS approach (Cornblatt et al., 2003) and in the 
schizotaxia concept (Tsuang, Stone, & Faraone, 2000; Tsuang, Stone, Tarbox, & 
Faraone, 2002). In identifying cognitive markers of psychosis risk, the association 
between different psychosis risk symptoms and cognitive performance can be 
recognized and addressed. 
Further, while psychotic disorders are linked to high rates of suicides and self-harm, 
it has also been noticed that there is an association between subclinical psychotic 
symptoms and suicidal behavior. This association has not been fully studied among 
adolescents referred to general psychiatric care, and it is addressed in this study. 
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2 Aims of the study 
The main aim of this study project was to systematically map the psychotic-like 
symptoms of the young patients seeking psychiatric care for the first time. The study 
also wanted to find out how usable the internationally used psychosis risk criteria and 
methods were in general adolescent psychiatric care. 
 
The specific aims of the study were: 
 
I) To investigate the association of cognitive performance and clinical high-
risk status and psychosis risk symptoms among adolescents in psychiatric 
care (Study I) 
 
II) To find out whether it is possible to predict psychosis and hospitalizations 
for psychotic disorder and any mental disorder with the SIPS interview in 
general adolescent psychiatric care (Study II) 
 
III) To explore the structural validity of the Prodromal Questionnaire and its 
ability to identify hospitalizations for psychotic disorder and any mental 
disorder in the following years (Study III) 
 
IV) To investigate the association of suicidality and self-harm with psychotic-
like symptoms and clinical high-risk status in a general adolescent 
psychiatric sample (Study IV) 
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3 Methods 
3.1 Participants 
The Helsinki Prodromal Study is a prospective study of psychosis risk conducted 
among adolescent psychiatric patients. The study cohort included all consecutive new 
patients aged 15–18 years who started their treatment in any public adolescent 
psychiatric outpatient and inpatient clinic or ward in Helsinki, Finland. Data were 
collected in two phases, 1.1.2003–15.3.2004 and 14.2.2007–31.12.2008, altogether 
constituting a three-year period. The only exclusion criterion for the study was previous 
psychiatric treatment within the preceding two years. At their first or second visit to the 
treating unit, the adolescents were asked to fill in the Finnish version of the Prodromal 
Questionnaire (PQ, Loewy et al., 2005), a self-report measure for screening psychosis 
risk symptoms.  
Based on the amount of patients visiting the units who were suitable for the study, 
the return rate of completed questionnaires was estimated at 75%. In total, 819 
questionnaires were returned. Some units also collected PQ data between the study 
periods but they were not used for screening. Excluding those with psychosis at the time 
the PQ was completed, or PQ dated between the two study periods, 683 adolescents 
were screened with the PQ; 90.0% were outpatients and 10.0% inpatients. 66.5% of the 
adolescents with PQ data were female and the average age was 16.5 years.  
As suggested by Loewy (2012), 18 or more positive symptom items of the PQ were 
used as the cut-off score for an in-depth assessment. The screen-positive adolescents 
numbered 145 (21.2%), with 538 screen-negative. All screen-positives were invited to 
the assessment as they were at psychosis risk according to the screening, and 114 agreed 
to participate. In addition, a random sample of 87 screen-negatives was invited as a 
clinical control group, and 60 participated. Altogether, 174 participants went through 
the whole research protocol. Of the interviewed sample, 89.7% were outpatients and the 
mean age was 16.6 years (16.5 for the girls and 17.0 for the boys). 77.0% were girls. Of 
the girls, 93.3% were outpatients, and of the boys, 77.5%. See Figure 1 for the 
participant flow diagram of the study. 
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In Study I, concerning psychotic-like symptoms and neurocognitive performance, the 
number of patient participants was 174, of whom 134 (77.0%) were female. In addition, 
72 volunteers from a local school acted as a cognitive performance control group.  
In Study II, with the topic of predicting psychosis with the SIPS, and Study IV, 
suicidality and psychotic-like symptoms, 13 participants were excluded from the 
interviewed sample because of lifetime SIPS or DSM-IV psychosis already at baseline 
(diagnoses not available at the time of Study I). The number of participants was thus 
161 in these two studies. Of them, 127 (78.9%) were female. 
In Study III, the sample size for the analyses was 731 adolescents with PQ data who 
had not refused use of register data or had not been diagnosed with psychosis during or 
before the same treatment episode as they completed the PQ. Of this study group, 496 
(67.9%) were female. 
 
3.2 Screening 
The Prodromal Questionnaire (PQ, Loewy et al., 2005) was designed because of the 
specific training and time required for the administration of psychosis risk interviews. 
The PQ, one of the most widely used psychosis risk questionnaires, is a self-report 
measure for screening putative prodromal symptoms. It has 92 items in a Yes/No format, 
grouped into positive, negative, disorganized, and general symptoms. Some of the items 
have been adapted from the SIPS interview probe questions. The PQ only takes 
approximately 10–20 minutes to complete and it is easy to score. As a limitation, all 
items are keyed so that a Yes response indicates a symptom, possibly resulting in 
response bias among participants.  
The PQ was translated into Finnish in 2001 and was available for this study. A cut-
off point of 18 or more positive symptoms was used, representing the top 20% of the 
distribution in the pilot phase of the Helsinki Prodromal Study. This cut-off score has 
been recommended by Loewy and colleagues (2012) reporting the results of the 
Helsinki Prodromal Study, with the PQ predicting CHR status with a sensitivity of 82% 
and specificity of 49%. Another widely used cut-off score is 14 or more positive 
symptoms, with 71% sensitivity and 81% specificity (Loewy et al., 2005). 
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A shorter version of 16 items has also been developed, with a sensitivity of 87% and 
specificity of 87% regarding psychosis risk or clinical psychosis in a help-seeking 
population (Ising et al., 2012).  
 
3.3 Cognitive testing 
The evaluations were conducted during two meetings that took place at the psychiatric 
unit where the participant was treated. The patients were administered a large, 
standardized neurocognitive test battery, which was designed to measure functions 
relevant to the neuropsychology of psychosis (Cannon et al., 2000; Stone, Gabrieli, 
Stebbins, & Sullivan, 1998). It consisted of subtests from internationally used 
standardized test batteries, such as WAIS-R, WAIS-III, WMS-R, and WMS-III, and of 
individual tests such as CVLT, Verbal Fluency Test, Trail Making Test and Dual Task 
that are commonly used in psychosis research. These tests assessed verbal and non-
verbal reasoning, verbal and visual memory, working memory, visuomotor speed, 
executive functioning, and attention. See Table 5 for description of the 
neuropsychological variables. 
Table 5. Description of neuropsychological variables used in the Helsinki Prodromal Study 
Ability Test 
Simple reaction time Computerized task; response time in milliseconds to randomly timed visual 
stimulus, as described in Therman (2009) 
Choice reaction time Computerized task; response time in milliseconds to correctly chosen response 
matching one of two stimuli, as described in Therman (2009)  
Verbal fluency Number of words generated in 1 minute in response to two letters (s, k) and one 
category (animals). Verbal fluency subtest of the Multilingual Aphasia 
Examination (Benton & Hamsher, 1976)  
Visuomotor speed  Connection of numbers in ascending sequence, seconds to completion; Trail 
Making Test subtest A (TMT-A) of Halstead-Reitan battery (Reitan & Wolfson, 
1985) with correction of errors 
Connection of letters in ascending sequence, seconds to completion; novel task 
named Trail Making Test subtest C, analogous to TMT-A 
Task switching Alternating connection of letters and numbers in ascending sequence, seconds to 
completion; Trail Making Test subtest B of Halstead-Reitan battery (Reitan & 
Wolfson, 1985) 
Processing speed Digit Symbol subtest of Wechsler Adult Intelligence Scale – revised (WAIS-R, 
Wechsler, 1981) 
Visuoconstructive 
ability  
Block design subtest of WAIS-R  
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Table 5. Description of neuropsychological variables used in the Helsinki Prodromal Study, continued 
Ability Test 
Verbal learning, 
immediate recall 
Words correctly recalled on five initial trials of California Verbal Learning Test 
I (CVLT I, Delis, Kramer, Kaplan, & Ober, 1987)  
Verbal learning, long 
delay  
Words correctly recalled in Long delay recall condition of CVLT I 
Verbal learning, 
recognition 
discriminability 
Discriminability index d’ in Recognition condition of CVLT I, calculated 
according to the corrected formula described in the CVLT II manual (Delis, 
Kramer, Kaplan, & Ober, 2000)  
Verbal episodic 
memory  
First story from Logical memory learning subtest of Wechsler Memory Scale – 
revised (WMS-R, Wechsler, 1987) 
Visual episodic 
memory 
Visual reproduction subtest of WMS-R 
Digit span Backward and forward scores on Digit span subtest of WMS-R 
Visual span Backward and forward scores on Visual span subtest of Wechsler Memory 
Scale – third edition (WMS-III, Wechsler, 1997b) 
General verbal ability  Abbreviated version of the Vocabulary subtest of WAIS-R  
Verbal abstraction 
ability  
Similarities subtest of WAIS-R  
Non-verbal reasoning Matrix reasoning subtest of Wechsler Adult Intelligence Scale – third edition 
(WAIS-III, Wechsler, 1997a) 
Counting backwards  Numbers correctly counted within 60 seconds minus errors, separate subtest 
condition of Bourdon-Wiersma dual task (Vilkki, Virtanen, Surma-Aho, & 
Servo, 1996) 
Dot cancellation Dots correctly cancelled within 60 seconds minus errors, separate subtest 
condition of Bourdon-Wiersma dual task (Vilkki et al., 1996) 
Dual task numbers Standardized residual of Counting backwards performance in dual task 
condition of Bourdon-Wiersma dual task, based on individual performance in 
Counting backwards and expected score distribution calculated from control 
group scores (Vilkki et al., 1996) 
Dual task dots Standardized residual of Dot cancellation performance in dual task condition of 
Bourdon-Wiersma dual task, based on individual performance in Dot 
cancellation and expected score distribution calculated from control group 
scores (Vilkki et al., 1996) 
Fine motor control Purdue pegboard subtasks: number of pins inserted with dominant hand in 30 
seconds (dominant hand); number of pins inserted with nondominant hand in 30 
seconds (nondominant hand); number of pin pairs inserted with both hands in 
30 seconds (pairs); number of parts assembled in 60 seconds (assembly). Tasks 
administered as detailed in the test manual (Purdue pegboard model #32020 
instructions and normative data, 1999) 
Speeded motor control Spatial tapping scores; novel motor test. Number of correct taps (minus errors) 
into large (easy) or small (difficult) circles in 10 seconds, keeping the best score 
of two trials 
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3.4 Interviews 
The participants were administered the Structured Interview for Prodromal Syndromes 
(SIPS, Miller et al., 2003), version 3.0. The SIPS addresses positive (psychotic-like), 
negative, disorganization, and general symptoms, and they are rated on 19 SOPS scales 
(Scale of Prodromal Symptoms), see Table 6.  
Based on the SIPS interview, the adolescents were divided into psychotic, clinical 
high-risk (CHR), and non-CHR groups. Three different kinds of risk states are rated 
with the method: Attenuated Positive Symptom (APS) syndrome, Brief Limited 
Intermittent Psychotic Symptoms (BLIPS), and Genetic Risk and Deterioration 
syndrome (GRD).  
The most common risk state is the APS. The criteria for it include a rating of 3–5 on 
any of the positive symptoms, with a frequency of at least once per week in the past 
month, and with the symptom having begun or worsened during the last year. In Table 7, 
an example of symptom severity assessment can be seen, with symptoms rated as 3, 4, 
or 5 representing possible psychosis risk symptoms. For every symptom, anchors are 
provided to give guidelines for the rater as examples of the symptoms. 
 
Table 6. SIPS symptom scales 
Positive symptoms Negative symptoms Disorganization 
symptoms 
General symptoms 
P1 Unusual thought 
content and delusional 
ideas 
N1 Social anhedonia or 
withdrawal 
D1 Odd behavior or 
appearance 
G1 Sleep disturbance 
P2 Suspiciousness and 
persecutory ideas 
N2 Avolition D2 Bizarre thinking G2 Dysphoric mood 
P3 Grandiosity N3 Decreased 
expression of emotions 
D3 Trouble with focus 
and attention 
G3 Motor 
disturbances 
P4 Perceptual 
abnormalities and 
hallucinations 
N4 Decreased 
experience of emotions 
and self 
D4 Personal hygiene / 
social attentiveness 
G4 Impaired 
tolerance to normal 
stress 
P5 Disorganized 
communication 
N5 Decreased ideational 
richness 
  
 N6 Deterioration in role 
functioning 
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Table 7. Severity scale of SIPS P4 Perceptual abnormalities and hallucinations. From SIPS 3.1 
(McGlashan, Woods, Rosen, Hoffman, & Davidson, 2001) 
Score Symptom description and anchors 
0 Absent   
1 Questionably 
present 
Minor, but noticeable changes in perceptual sensitivity (e.g. heightened, dulled, 
distorted) 
2 Mild Unexpected, unformed perceptual changes that are puzzling but are not considered 
to be significant 
3 Moderate Repeated, unformed images (shadows, trails, sounds, etc.), illusions, or persistent 
perceptual distortions that may be worrisome or experienced as unusual 
4 Moderately 
severe 
Recurrent illusions or momentary hallucinations that are recognized as not real yet 
can be frightening or captivating, and may affect behavior slightly. Not sure of 
source of experiences 
5 Severe but not 
psychotic 
Hallucinations that occasionally affect thinking or behavior, experienced as possibly 
external to self or real. Skepticism can be induced 
6 Psychotic Recurrent hallucinations perceived as real and distinct from the person's thoughts. 
Clearly influence thinking, feeling, and/or behavior. Skepticism cannot be induced 
 
The adolescents were also interviewed with the Structured Clinical Interview for the 
DSM-IV, Clinician Version (SCID, First, Spitzer, Gibbon, & Williams, 1996). The 
diagnostic assessments were completed at the National Institute for Health and Welfare. 
The research staff was trained to high standards of reliability on the SCID by Professor 
Jaana Suvisaari, MD. In 2002, they completed a three-day SIPS training workshop with 
Rachel Loewy and excellent inter-rater agreement (kappa=.97 for CHR status) was 
achieved. Most of the SIPS ratings were assigned by team consensus using a videotaped 
interview, blind to the screening status of the participant. 
 
3.5 Other clinical data 
As a part of the study protocol, the participants also completed the Beck Depression 
Inventory II (BDI-II, Beck, Steer, & Brown, 1996), the Beck Anxiety Inventory (BAI, 
Beck, Epstein, Brown, & Steer, 1988), and the Beck Hopelessness Scale (BHS, Beck, 
Weissman, Lester, & Trexler, 1974). 
 Complete medical records were available for 170 of the 174 participants (97.7%). 
DSM-IV Axis I diagnoses were made (n=169) using all available data including 
medical records, and six diagnosis clusters were formed: 1) psychotic disorder, 2) non-
psychotic mood disorder, 3) anxiety disorder, 4) eating disorder, 5) substance-related 
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disorder, and 6) disorder usually first diagnosed in infancy, childhood, or adolescence. 
The baseline diagnosis was made blind to follow-up information. 
 Global Functioning: Social and Global Functioning: Role (Cornblatt et al., 2007) 
were scored for the adolescents based on interview data and medical records. In addition, 
based on all available data, each participant was rated for having been bullied at school 
(Yes/No). Similarly, family background, i.e. if they had always lived at home with both 
parents without any child welfare intervention was scored as Yes/No. This variable was 
formed in this manner because of the difficulty of forming groups with the variety of 
different family situations of the adolescents. Age of onset of the first psychiatric 
symptom and age of treatment onset were scored. Aggression was assessed with two 
variables, “threatened with violence” and “has been physically violent towards others”, 
both scored using all available information and scored as Yes/No. 
 Suicidality at baseline was assessed in two ways: Current suicidality data was 
gathered from BDI-II item 9, and was available for 151 (93.8%) participants. Filling out 
the BDI, patients were asked to rate their agreement on a four-point scale according to 
how they have felt lately. The options were: 0) "I don’t have any thoughts of killing 
myself” (no ideation), 1) "I have thoughts of killing myself but I would not carry them 
out" (mild ideation), 2) "I would like to kill myself" (moderate ideation), and 3) "I 
would kill myself if I had the chance" (severe ideation). Lifetime suicidality was 
assessed based on all available data including patient files and interview data 
concerning the patient’s whole life before baseline, i.e. the day of the SIPS interview. 
Adolescents were classified on a scale of 0–3, the options being: 0) not suicidal, 1) 
thinking of death or having death wishes, 2) suicidal thoughts, 3) self-harm (intention to 
die not assessed). 
 
3.6 Follow-up 
Follow up information was gathered from three sources. Firstly, there was a one-year 
follow-up assessment including SCID and SIPS interviews for a proportion (n=61) of 
the participants. At the first phase of the study (2003–2004), only CHR patients were 
invited to follow-up if they had given permission to contact them (n=26). However, 
SIPS was not part of the procedure and was done with only three patients. At the second 
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phase of the study (2007–2008), all participants who had given permission to be 
contacted (n=88) were invited and SIPS data was gathered from 58. Secondly, follow-
up information from the medical records of the participants was collected for the total 
duration of their psychiatric treatment.  
 DSM-IV Axis I diagnoses were made for follow-up (1 year or less if the treatment 
had ended before that, n=156) using all available data, medical records and follow-up 
assessment. Conversion to psychosis was assessed separately as defined by SIPS and by 
DSM-IV. As defined by SIPS, conversion to psychosis meant a positive symptom rated 
six with either a frequency of ≥1h/day four days/week during the past month or being a 
seriously disorganizing or dangerous symptom. A scoring of six is given for symptoms 
where there is delusional conviction with no doubt at least intermittently, or there are 
recurrent hallucinations perceived as real and distinct from own thoughts, affecting 
functioning. 
 Thirdly, register data was used from the Finnish Hospital Discharge Register 
HILMO (Care Register for Health Care) of the adolescents’ treatments, medications, 
and diagnoses until the end of 2011, giving a register follow-up time of 1025–3249 days 
(2.8–8.9); mean 2058 days (5.6 years), standard deviation 823 days. The diagnostic 
system used in the register is the International Classification of Diseases, 10th edition 
(ICD-10). Outcome variables derived from the register were psychotic disorders (ICD-
10 codes F20, F22–F29, F30.2, F31.2, F31.5, F32.3, or F33.3), psychiatric hospital 
treatments (a stay at a psychiatric hospital, or any hospital stay with a primary or 
secondary psychiatric diagnosis, ICD-10 codes F00–F99, X60–X85, or Y87.0), and 
intentional self-harm (ICD-10 codes X69–X84, Y87, Y87.0, Z91.5, or Z72.8). 
Permission to register follow-up was available for 154 participants. The register 
includes both public and private hospitals, and it has an excellent accuracy in detecting 
psychoses (Perälä et al., 2007). Data of completed suicides were also gathered from the 
Causes of death statistics (Statistics Finland). 
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3.7 Data analysis 
In Study I, the data were analyzed using the IBM SPSS 15.0 statistical package. 
Adolescents were divided into those who fulfilled the clinical high-risk (CHR) criteria 
and those who did not (non-CHR) based on the SIPS interview. Missing 
neuropsychological test scores (3.5% of all scores) were replaced with expectation-
maximization algorithm estimates based on all available scores. All test results were 
transformed so that higher scores on the subtest indicated better performance. Maximum 
likelihood factor analyses were conducted for the SIPS symptoms and the 
neurocognitive tests with Varimax rotation, and standardized factor scores were 
extracted. Mann-Whitney test and Cohen's d were used to examine associations between 
variables and to compare the cognitive performance between groups. Spearman 
correlations between symptom and cognitive factors were calculated for the groups 
separately. 
In Study II, gender, participation rate, and screening outcome of the participants were 
taken into account using weights in all analyses. R 3.0.1 (R Core Team, 2013) and its 
packages survival (Therneau, 2013) and survey (Lumley, 2012) were therefore used. 
Screening weight for the screen-positives was 1, as they were all selected to the study. 
For the screen-negatives, screening weight was returned PQ’s (538) / selected cases (86) 
= 6.256. Attrition weights were calculated for the screen-positives by dividing their total 
number (145) by the number interviewed (114) = 1.272; and in the same way for the 
screen-negatives: 538/60=8.967 (Pickles, Dunn, & Vázquez-Barquero, 1995). Total 
weights were calculated by screening weights X attrition weights. They were then 
scaled into analysis weights so that their sum was = N. All weights were calculated 
separately for males and females. 
SIPS and DSM-IV psychosis conversion at the one-year follow-up was assessed for 
the 148 participants with adequate follow-up data. Sensitivity, specificity, positive 
predictive value, and negative predictive value of the CHR status were calculated. 
Additionally, an adjusted Wald test of association (Thomas & Rao, 1987) was used. 
Register follow-up analyses were conducted with Cox regression survival analysis. 
From the interviewed 174 adolescents, those with baseline SIPS (n=5) or DSM-IV 
psychosis (n=8) were excluded from these analyses, as were those without permission to 
register follow-up (n=7), leaving a group of 154 participants. The hazard ratios of 
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hospitalization for psychosis and any psychiatric disorder were calculated without those 
with such hospitalization at baseline, leading to groups of 149 (hospitalization for 
psychosis) and 133 participants (hospitalization for any psychiatric disorder). CHR 
status and symptom factors derived from the SIPS were used as predictors of hospital 
treatment. In all the regression analyses, gender was included as stratum. 
In Study III, MPLUS version 7.11 (Muthén & Muthén, 2012) was used. Exploratory 
factor analysis of the 731 response sets was conducted with the WLSMV algorithm and 
default parameters. Symptom factor scores and PQ Total and Positive subscale sum 
scores were used as predictors in Cox proportional hazards models of any psychiatric 
hospitalization and hospitalization with a psychosis diagnosis. Predictors were first 
entered individually, and those significant at the p=.01 level were included in a forward-
stepping Cox model. Before survival analyses, all factor scores and PQ sum scores were 
normalized. Survival analyses were conducted with gender as a stratum. One-year 
predictive values for psychosis of the previously (Loewy, Johnson, & Cannon, 2007) 
suggested cut-offs for the positive symptoms subscale (at least 14 symptoms) and total 
sum score (at least 36 symptoms) were also assessed. 
In Study IV, the data were analyzed using the IBM SPSS Statistics 21. The group 
comparisons for categorical variables were calculated using the Pearson’s χ2 and 
Fisher’s Exact test. The Mann-Whitney U test was used for comparisons in ordinal or 
non-normally distributed continuous variables. Symptom factors derived from the SIPS 
were used in addition to SIPS subscale scores and CHR status. Because the BDI-II item 
9 was used to assess current suicidality, the BDI total score was calculated without this 
item in Study IV. Spearman correlations were calculated to investigate associations 
between continuous or ordinal variables. Analyses of intentional self-harm during 
follow-up were calculated among females only, as all patients with intentional self-harm 
resulting in hospitalization were female. A Cox regression analysis was performed to 
predict hospital-treated self-harm during follow-up among the 121 girls with permission 
to use register data. The significant variables in bivariate analyses were entered into the 
model and forward selection model was used. 
All statistical tests across the studies were two-tailed. P-values <.05 and hazard ratios 
(HR) with 95% confidence intervals (95% CI) were considered statistically significant.  
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3.8 Attrition analysis 
Participants were enrolled to the study by the Prodromal Questionnaire which was 
instructed to be given to every new adolescent patient in the clinics and wards. 
Approximately 75% of the eligible patients filled in the questionnaire and 819 
questionnaires were returned (Figure 1). Of those, participants with psychosis diagnosis 
at baseline were excluded, as were those refusing register follow-up. Those who had 
filled in the questionnaire between the study periods when screening for interview was 
not done were also excluded.  
Of the group of 683 adolescents eligible for screening (of whom 66.3% were girls), 
all screen-positives were invited to the interview (124 girls and 21 boys). 78.6% 
participated (99 girls and 15 boys). Of the screen-negatives, 50 girls and 36 boys were 
invited and 69.0% of them participated in the study, of whom 35 were girls and 25 boys. 
 
3.9 Ethical considerations  
The adolescents gave written informed consent to participate in the study. As they were 
aged at least 15 years, consent from their parents was not needed but the parents 
received an information letter of the study. Inclusion in the study was voluntary and it 
did not affect the treatment the adolescents had in the psychiatric unit. 
If the adolescent gave permission, the SIPS interview was videotaped to improve the 
accuracy and reliability of the scoring of the interview. The tapes were destroyed after 
the scoring or after 2 years at the latest. 
The participants were asked if their medical records could be used in the study and if 
they provided register follow-up permission. They were also asked if they could be 
contacted for inquiry about follow-up study phases in 6 or 12 months. A small 
compensation was paid to the adolescents participating in the follow-up studies.  
The study protocol was reviewed and approved by the institutional review boards of 
the National Public Health Institute (the National Institute for Health and Welfare since 
2009) and the Ethics Committee for gynaecology and obstetrics, pediatrics and 
psychiatry of the Hospital District of Helsinki and Uusimaa. The study was carried out 
in accordance with the Declaration of Helsinki. 
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4 Results 
4.1 Characteristics of the study group 
731 adolescents completed the PQ and 174 were interviewed. At the baseline interview, 
54 of the 161 non-psychotic adolescents (33.5%) met criteria for at least one of the SIPS 
prodromal syndromes (CHR group) and 107 (66.5%) were considered non-CHR. Of the 
girls, 34.6% fulfilled the CHR criteria, and of the boys, 29.4%. Almost all fulfilling the 
CHR criteria met criteria for Attenuated Positive Prodromal Syndrome (APS, 51 
adolescents), one for Genetic Risk and Deterioration syndrome (GRD), and two for both 
risk syndromes. The characteristics of the CHR and non-CHR groups can be seen in 
Table 8. Of the PQ screen-positive, 40.2% met the psychosis risk criteria, whereas 
20.4% of the PQ screen-negative met the risk criteria. See Table 9 for a cross-tabulation 
of screening results and interview assessed psychosis risk. 
 
4.2 Cognitive performance and psychotic-like symptoms (Study I) 
A three-factor model of the neurocognitive test scores was formed and the factors 
identified as processing speed, verbal performance, and visuospatial performance (Table 
10). As the only gender difference, girls’ performance was better in the processing 
speed factor compared to boys (Mann-Whitney U=2357, p=.013; and Cohen's d=0.5).  
Symptom levels of CHR and non-CHR groups can be seen in Table 11. SIPS 
symptoms formed three factors that were interpreted as general, positive, and negative 
symptoms (Table 12). Compared to boys, girls had higher general symptoms scores 
(Mann-Whitney U=1764, p=.001; and Cohen's d=0.6). There were no other gender 
differences. 
At the test level, there were tasks from all three cognitive factors—processing speed, 
verbal performance, and visuospatial performance—in which non-CHR adolescents 
performed better than the CHR group. CHR status was associated with impaired 
visuospatial task performance (Mann-Whitney U=2641, p=.009; and Cohen's d=0.5). 
However, both positive and negative symptoms were associated with lower levels of 
neurocognitive functioning among adolescents in psychiatric treatment, regardless of 
CHR status. Among patients in the CHR group, negative symptoms correlated 
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negatively with processing speed (r=−.31, p<.05) and verbal performance (r=−.37, 
p<.01). Among non-CHR patients, there were negative correlations between negative 
symptoms and verbal performance (r=−.19, p<.05), and positive symptoms and 
visuospatial performance (r=−.24, p<.05). 
 
Table 8. Demographic and clinical data for the interviewed participants at baseline, those with psychosis 
excluded 
 Total,  
n=161 
CHR,  
n=54 (33.5%) 
non-CHR,  
n=107 (66.5%) 
Female 127 (78.9%) 44 (81.5%) 83 (77.6%) 
Age (years); range,  
mean (sd) 
15.2-18.3,  
16.6 (.85) 
15.2-18.1,  
16.7 (.85) 
15.2-18.3,  
16.6 (.85) 
Age of symptom onset (years); range,  
mean (sd) 
7-18,  
14.0 (2.3) 
7-17,  
13.8 (2.5) 
7-18,  
14.1 (2.3) 
Age of treatment onset (years); range,  
mean (sd) 
7-18,  
15.2 (2.1) 
7-18,  
14.7 (2.5) 
7-18,  
15.4 (1.9) 
Inpatient (at the time of the PQ) 11 (6.8%) 4 (7.4%) 7 (6.5%) 
PQ screen-positive (18+ positive symptom 
items) 
107 (66.5%) 43 (79.6%) 64 (59.8%) 
PQ screen-negative, clinical control group 54 (33.5%) 11 (20.4%) 43 (40.2%) 
Born in Finland and has Finnish parents 144 (89.4%) 48 (88.9%) 96 (89.7%) 
Family structure: two-parent family without 
any child welfare intervention 
66 (41.0%) 18 (33.3%) 48 (44.9%) 
First-degree relative with psychosis or bipolar 
disorder 
10 (6.2%) 7 (13.0%) 3 (2.8%) 
Second-degree relative with psychosis or 
bipolar disorder 
13 (8.1%) 6 (11.1%) 7 (6.5%) 
Substance abuse of a first-degree relative 51 (31.7%) 22 (40.7%) 29 (27.1%) 
Bullied at school 62 (38.5%) 22 (40.7%) 40 (37.4%) 
Global Functioning: Social, range, mean (sd) 3-9, 7.0 (1.2) 3-9, 6.6 (1.3) 4-9, 7.2 (1.0) 
Global Functioning: Role, range,  
mean (sd) 
3-9,  
6.5 (1.4) 
4-8,  
6.1 (1.3) 
3-9,  
6.7 (1.4) 
BDI-II (item 9 excluded), range,  
mean (sd) 
0-57,  
22.5 (13.1) 
6-57,  
28.3 (13.2) 
0-52,  
19.7 (12.2) 
BAI, range, mean (sd) 0-45, 16.3 (9.4) 2-41, 19.2 (9.5) 0-45, 15.0 (9.1) 
BHS, range, mean (sd) 0-20, 9.7 (5.4) 1-20, 11.4 (5.6) 0-20, 8.9 (5.1) 
No psychiatric medication 94 (58.4%) 23 (42.6%) 71 (66.4%) 
Diagnosis clusters at baseline 
a
    
Any non-psychotic mood disorder diagnosis 122 (75.8%) 47 (87.0%) 75 (70.1%) 
Any anxiety disorder diagnosis 51 (31.7%) 20 (37.0%) 31 (29.0%)  
Any eating disorder diagnosis 15 (9.3%) 1 (1.9%) 14 (13.1%) 
Any substance-related diagnosis 23 (14.3%) 8 (14.8%) 15 (14.0%) 
Any disorder usually first diagnosed in 
infancy, childhood, or adolescence 
22 (13.7%) 6 (11.1%) 16 (15.0%) 
a
 The same person can have diagnoses from multiple clusters so the numbers exceed 100%. 
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Table 9. PQ screening and CHR status among adolescents 
 SIPS psychosis risk status Total 
CHR non-CHR 
n % n % n % 
PQ screening result Screen-negative 11 20.4 43 40.2 54 33.5 
Screen-positive 43 79.6 64 59.8 107 66.5 
Total 54  107  161  
 
Table 10. Three-dimensional structure of cognitive performance. Maximum Likelihood model with 
Varimax rotation 
Factors  Test variables with factor loading >0.4 
Processing speed Purdue pegboard nondominant hand 
 Digit symbol 
 Trail Making A 
 Purdue pegboard pairs 
 Purdue pegboard dominant hand 
 Spatial tapping (easy) 
 Purdue pegboard assembly 
 Spatial tapping (difficult) 
 Dot cancellation 
 Trail Making C 
 Trail Making B 
 Simple reaction time 
 Choice reaction time 
 Fluency K 
 Counting backwards 
Verbal performance Logical memory, immediate recall 
 Logical memory, delayed recall 
 Verbal learning, immediate recall 
 Vocabulary 
 Verbal learning, long delay 
 Similarities  
 Verbal learning, recognition discriminability 
Visuospatial performance Block design 
 Visual reproduction, delayed recall 
 Matrix reasoning 
 Visual reproduction, immediate recall 
 Similarities 
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Table 11. SIPS baseline symptom scores of the 161 non-psychotic participants 
 
Total, n=161 Male, n=34 Female, n=127 CHR, n=54 non-CHR, n=107 
 
Mean SD Mean SD Mean SD Mean SD Mean SD 
P1 Unusual thought content 
and delusional ideas 
1.9 1.5 1.4 1.4 2.0 1.5 3.1 1.2 1.3 1.2 
P2 Suspiciousness and 
persecutory ideas 
1.7 1.2 1.3 1.4 1.9 1.2 2.7 1.2 1.3 1.0 
P3 Grandiosity 
 
0.5 0.9 0.5 1.0 0.6 0.9 1.0 1.2 0.3 0.7 
P4 Perceptual abnormalities 
and hallucinations 
1.9 1.6 1.4 1.5 2.0 1.7 3.2 1.5 1.2 1.3 
P5 Disorganized 
communication 
0.7 0.8 0.8 1.2 0.7 0.7 1.0 1.0 0.5 0.7 
N1 Social anhedonia or 
withdrawal 
1.6 1.4 1.8 1.8 1.5 1.3 2.3 1.6 1.3 1.2 
N2 Avolition 
 
2.4 1.4 2.0 1.6 2.5 1.4 3.1 1.4 2.1 1.3 
N3 Decreased expression of 
emotions 
1.2 1.3 1.3 1.7 1.2 1.1 1.7 1.4 1.0 1.1 
N4 Decreased experience of 
emotions and self 
1.9 1.5 1.3 1.2 2.0 1.6 2.7 1.5 1.4 1.4 
N5 Decreased ideational 
richness 
0.6 0.9 0.9 1.0 0.6 0.9 1.0 1.1 0.5 0.8 
N6 Deterioration in role 
functioning 
2.8 1.5 2.6 1.7 2.8 1.5 3.5 1.5 2.4 1.4 
D1 Odd behavior or 
appearance 
1.3 1.2 1.5 1.3 1.3 1.1 1.7 1.1 1.2 1.1 
D2 Bizarre thinking 
 
0.8 1.0 0.6 0.9 0.8 1.1 1.3 1.1 0.5 0.9 
D3 Trouble with focus and 
attention 
1.9 1.0 1.6 0.9 2.0 1.0 2.5 0.8 1.7 1.0 
D4 Personal hygiene / social 
attentiveness 
0.5 0.9 0.7 1.0 0.5 0.9 0.7 1.1 0.4 0.8 
G1 Sleep disturbance 
 
2.4 1.4 2.1 1.3 2.5 1.4 2.9 1.5 2.1 1.3 
G2 Dysphoric mood 
 
3.7 1.5 3.0 1.7 3.8 1.3 4.4 1.0 3.3 1.5 
G3 Motor disturbances 
 
0.5 0.8 0.4 0.9 0.5 0.8 0.7 0.9 0.3 0.7 
G4 Impaired tolerance to 
normal stress 
2.4 1.7 1.9 1.7 2.6 1.6 3.1 1.6 2.1 1.6 
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Table 12. Three-dimensional structure of SIPS symptoms. Maximum Likelihood model with Varimax 
rotation 
Factors  SIPS symptoms with factor loading >0.4 
General symptoms G2 Dysphoric mood  
 N2 Avolition 
 G1 Sleep disturbance  
 G4 Impaired tolerance to normal stress 
 N6 Deterioration in role functioning 
 D3 Trouble with focus and attention 
 N4 Decreased experience of emotions and self 
 P2 Suspiciousness and persecutory ideas 
Positive symptoms P1 Unusual thought content and delusional ideas 
 D2 Bizarre thinking 
 P4 Perceptual abnormalities and hallucinations 
 P2 Suspiciousness and persecutory ideas 
 D1 Odd behavior or appearance 
 N4 Decreased experience of emotions and self 
 P3 Grandiosity  
 P5 Disorganized communication 
Negative symptoms N1 Social anhedonia or withdrawal 
 N3 Decreased expression of emotions 
 D1 Odd behavior or appearance 
 D4 Personal hygiene / social attentiveness 
 N5 Decreased ideational richness 
 G3 Motor disturbances  
 
4.3 Predicting psychosis with the SIPS interview (Study II) 
At baseline, the participants were mostly diagnosed with non-psychotic mood disorders 
(76%), anxiety disorders (32%), and substance-related disorders (14%). Mood disorders 
were more prevalent in the CHR group than in the non-CHR group (Fisher’s exact test, 
p=.020), and eating disorders more prevalent in the non-CHR group compared to the 
CHR group (Fisher’s exact test, p=.021).  
Mood disorders were especially prevalent among girls (81% of girls, 56% of boys). 
Anxiety disorders were the second largest diagnosis group for both genders (32% of 
girls, 29% of boys). For girls, the next diagnosis clusters were substance-related 
disorders (13%) and eating disorders (11%), and for boys, disorders usually first 
diagnosed in infancy, childhood, or adolescence (such as conduct disorder, ADHD, 
Asperger’s syndrome; 32%) and substance-related disorders (18%). 
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During the 12-month follow-up, three (2.0%) of the 148 subjects developed 
psychosis as defined by SIPS (Figure 2). Of 51 CHR individuals with follow-up data, 
two (3.9%) converted. One of the 97 non-CHR individuals (1.0%) transitioned as well. 
CHR status did not predict psychosis, [F(1,147)=.004, p=.949]. The weighted 
sensitivity of the CHR status was 23% and specificity 76%.  
Using the DSM-IV criteria for psychosis instead, five adolescents (3.4%) developed 
a psychotic disorder over follow-up. Three of the converters belonged to the CHR group 
so conversion took place for 5.9% of the CHR group. CHR status did not predict 
transition to DSM-IV psychosis either [F(1,147)=.05, p=.831]. The sensitivity and 
specificity of the risk status were 28% and 76%, respectively. 
During the maximum of 9 years of register follow-up, seven admissions for 
psychosis emerged (four female, three male). Four persons (8.5%) of the CHR group 
and three (2.9%) of the non-CHR group were hospitalized for psychosis. The sensitivity 
and specificity of the CHR status were 40% and 80%, respectively. CHR status did not 
predict psychotic disorders in a regression model [HR=2.2, p=.284, 95%CI=.5–9.0]. The 
Kaplan-Meier survival curves by risk status are shown in Figure 3. In a separate Cox 
analysis, psychotic disorders were predicted by SIPS positive symptom factor [HR=2.2, 
p=.016, 95%CI=1.2–4.2] and not by general and negative symptoms.  
During the follow-up time, there were 26 psychiatric hospitalization events. In a Cox 
regression model, they were predicted by CHR status [HR=3.1, p=.005, 95%CI =1.4–
6.9], positive symptoms [HR=1.9, p=.001, 95%CI=1.3–2.9], and general symptoms 
[HR=2.2, p=.001, 95%CI=1.4–3.6].  
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Figure 2. Follow-up data of participants by group 
         
Figure 3. Cumulative survival distribution function modeling time to psychosis by CHR status 
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4.4 Predicting psychosis with the PQ questionnaire (Study III) 
The Prodromal Questionnaire had high endorsement rates. The endorsement level of the 
individual items was lowest for items 84 and 79 [“I have seen things that other people 
can't see or don't seem to” and “I have seen unusual things like flashes, flames, blinding 
light, or geometric figures”] at 7.4% and 8.2%, and highest for items 28 and 8 [“I have 
been feeling unhappy or depressed lately” and “I often seem to live through events 
exactly as they happened before (déjà vu)”] at 67.9% and 67.1%.  
A nine-factor latent structure was identified, the factors interpreted as role 
functioning, delusional ideation, hallucinations, oddness, social avoidance, magical 
thinking, dysphoria, depersonalization, and anhedonia (Table 13). Of the 731 adolescent 
psychiatric patients who completed the Prodromal Questionnaire at the clinic or ward at 
the beginning of their treatment, 120 were hospitalized during the register follow-up 
time, 41 with a psychosis diagnosis.  
Of the factors, depersonalization predicted later hospitalization with a psychosis 
diagnosis (HR=1.6, p=.005, 95%CI=1.2–2.2). Examples of the PQ items loading on the 
depersonalization factor are “I have felt like I am at a distance from myself, as if I am 
outside my own body or that a part of my body did not belong to me” and “I have felt 
like I am looking at myself as in a movie, or that I am a spectator in my own life”.  
Role functioning predicted psychiatric hospitalizations overall (HR=1.3, p=.002, 
95%CI=1.1–1.6). PQ items loading on the role functioning include “I have had troubles 
at work or school recently”, “I am less interested in school or work lately”, and “I have 
difficulty concentrating, reading or listening”. 
At 12 months, the criterion of 14 or more positive subscale symptoms provided a 
48% sensitivity and 68% specificity for predicting psychosis. Using 18 positive 
symptoms as a cut-off instead, the sensitivity dropped to 28% and specificity raised to 
81%. The total score criterion of 36 or more Yes responses had a 64% sensitivity and a 
57% specificity. 
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Table 13. Nine-dimensional structure of Prodromal Questionnaire items 
Factors  
 
PQ items with factor loading >0.4 Item content 
F1 Role functioning PQ11 trouble at school 
 PQ41 less interested in school 
 PQ10 trouble concentrating 
 PQ72 less able to do tasks 
 PQ85 fatigue 
 PQ01 distracted by noise 
F2 Delusional ideation PQ12 others read thoughts 
 PQ32 thoughts broadcast 
 PQ38 people are watching 
 PQ76 people drop hints 
F3 Hallucinations PQ18 unusual sounds 
 PQ13 hearing things 
 PQ84 see things 
 PQ19 illusions of people 
 PQ79 see flashes 
 PQ05 bugs on skin 
 PQ26 strong sense of smell 
 PQ50 suddenly distracted 
 PQ57 reality confusion 
 PQ52 invisible force around 
F4 Oddness PQ31 strange person 
 PQ54 eccentric habits 
 PQ45 odd person 
 PQ62 strange ideas 
 PQ40 mannerisms 
 PQ15 collect unvalued things 
 PQ69 unusual word use 
 PQ22 odd appearance 
 PQ76 people drop hints 
 PQ61 bizarre beliefs 
F5 Social avoidance PQ43 social avoidance 
 PQ21 quiet socially 
 PQ78 not interested in new acquaintances 
 PQ33 nothing to say 
 PQ42 emotionally distant 
 PQ58 aloof and distant 
 PQ87 social anxiety 
 PQ59 hiding feelings 
 PQ80 anxious meeting strangers 
 PQ06 don't get along 
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Table 13. Nine-dimensional structure of Prodromal Questionnaire items, continued 
Factors  
 
PQ items with factor loading >0.4 Item content 
F6 Magical thinking PQ24 belief in telepathy 
 PQ35 superstitious 
 PQ75 supernatural experiences 
 PQ61 bizarre beliefs 
 PQ30 special gifts 
F7 Dysphoria PQ83 cry often 
 PQ47 unstable mood 
 PQ28 unhappy 
 PQ44 very guilty 
 PQ70 often angry 
 PQ55 something wrong with mind 
 PQ29 brooding 
 PQ88 hard to relax 
 PQ63 feeling worthless 
 PQ25 suspiciousness 
F8 Depersonalization PQ81 outside body experiences 
 PQ71 spectator in life 
 PQ65 thoughts almost audible 
 PQ37 many thoughts compete 
 PQ36 heard own thoughts 
 PQ27 not in control of thoughts 
 PQ67 arranged meanings in things 
 PQ46 special meanings on TV 
 PQ20 vision changes 
 PQ02 altered passage of time 
 PQ74 some force interferes 
F9 Anhedonia PQ48 unable to enjoy 
 PQ89 uninterested 
 PQ82 dulled feelings 
 
4.5 Self-harm and psychotic-like symptoms (Study IV) 
Only 30.5% of the adolescents interviewed reported no suicidal ideation in the BDI 
questionnaire (Table 14). The scores for current suicidality were higher among girls 
compared to boys and among the CHR group compared to the non-CHR group. Over a 
third of all the participants and 41% of all female patients were rated as having harmed 
themselves over their lifetime. This included, for instance, cutting and overdoses of 
medication. 
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Table 14. Current and lifetime suicidality among participants 
 Total Female Male CHR non-CHR 
n % n % n % n % n % 
Current suicidality 
0 No ideation 46/151 30.5 29/118 24.6 17/33 51.5 11/49 22.4 35/102 34.3 
1 Mild ideation 81/151 53.6 68/118 57.6 13/33 39.4 26/49 53.1 55/102 53.9 
2 Moderate ideation 18/151 11.9 16/118 13.6 2/33 6.1 8/49 16.3 10/102 9.8 
3 Severe ideation 6/151 4.0 5/118 4.2 1/33 3.0 4/49 8.2 2/102 2.0 
Lifetime suicidality  
0 Not suicidal 34/161 21.1 25/127 19.7 9/34 26.5 9/54 16.7 25/107 23.4 
1 Thinking of death or death 
wishes 
25/161 15.5 20/127 15.7 5/34 14.7 10/54 18.5 15/107 14.0 
2 Suicidal thoughts 44/161 27.3 30/127 23.6 14/34 41.2 16/54 29.6 28/107 26.2 
3 Self-harm  58/161 36.0 52/127 40.9 6/34 17.6 19/54 35.2 39/107 36.4 
  
 Compared to the non-CHR group, the CHR group scored higher in current suicidality 
(Mann-Whitney U=2016.5, n1=49, n2=102, p=.034) but not in lifetime suicidality. 
Current suicidality was positively correlated with SIPS general and negative symptom 
factors and several positive, negative, and general symptom scales. Lifetime suicidality 
was correlated with SIPS general symptom factor and some negative and general 
symptom ratings. Of the Beck scale scores, BAI was correlated with current suicidality, 
and BDI and BHS with both suicidality measures. 
 Girls reported more current suicidality compared to boys (Mann-Whitney U=1391.0, 
n1=118, n2=33, p=.006). The gender difference in lifetime suicidality was not 
statistically significant. Non-intact family structure (Mann-Whitney U=3400.5, n1=66, 
n2=85, p=.020) and substance abuse of a first-degree relative (U=3387.5, n1=106, n2=51, 
p=.007) were associated with higher scores in lifetime suicidality. There was a higher 
risk for suicidality among those with any non-psychotic mood disorder present at 
baseline compared to those without such a diagnosis, for both current (Mann-Whitney 
U=1436.0, n1=115, n2=36, p=.002) and lifetime suicidality (U=3345.0, n1=122, n2=39, 
p<.001). There was no significant difference in suicidality between those with and 
without other disorder cluster diagnoses.  
 There was one completed suicide in the sample and in addition, based on the hospital 
discharge register, four girls had intentionally harmed themselves during follow-up 
(ICD diagnosis code X69 Intentional self-poisoning in all cases). Altogether, there were 
five patients (3.2%) with intentional self-harm. Adolescents with a psychosis risk status 
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did not harm themselves more than the non-CHR adolescents (Fisher’s exact test, 
p=.661).  
 Self-harm during follow-up was associated with current suicidality (Mann-Whitney 
U=129.5, n1=5, n2=108, p=.027) and familial risk of psychosis (U=195.5, n1=5, n2=113, 
p=.027). SIPS scale N3 “Decreased expression of emotions” was higher among the 
patients with intentional self-harm (Mann-Whitney U=130.5, n1=5, n2=116, p=.030). In 
a Cox regression analysis among the 121 girls, this SIPS scale remained a significant 
predictor of self-harm during follow-up (HR=2.8, p=.004, 95%CI=1.4–5.5). 
 Two of the five patients with intentional self-harm were admitted to hospital care for 
psychosis before the self-harm and the association between transition to psychosis and 
self-harm was significant (Fisher’s exact test, p=.008); see Table 15.  
 
 
Table 15. Transition to psychosis and intentional self-harm during follow-up among girls with register 
follow-up data 
 Psychosis Total 
Yes No 
n % n % n % 
Intentional self-harm No 2 50.0 114 97.4 116 95.9 
Yes 2 50.0 3 2.6 5 4.1 
Total 4  117  121  
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5 Discussion 
5.1 Summary of the main findings 
The main aim of this study was to investigate whether clinical high-risk state or certain 
symptoms predict psychosis or psychiatric hospitalization in the following years in a 
general adolescent psychiatric sample. Secondly, this study aimed at looking for 
possible associations between cognitive performance and suicidality with psychosis risk 
symptoms in the sample. 
Using the Prodromal Questionnaire (PQ) screen with a cut-off of 18 or more positive 
symptoms, there were 107 screen-positive and 54 screen-negative participants. 
Furthermore, a third of the interviewed sample of adolescents in general psychiatric care 
fulfilled the SIPS criteria of psychosis risk; 40% of those who were screened positive in 
PQ and 20% of those who were screen-negative.  
Psychosis risk status was associated with deficits in visuospatial performance. 
However, both positive psychotic-like symptoms and negative symptoms were 
associated with neurocognitive problems regardless of the risk status. As cognitive 
deficits may be associated with lowered daily functioning, it can be concluded that even 
mild positive and negative symptoms have clinical relevance among adolescent 
psychiatric patients. 
During the 3–9 year register follow-up, 5.6% of all who had completed the 
Prodromal Questionnaire were hospitalized for psychosis. The prevalence of transition 
to psychotic disorder was also low among the SIPS interviewed sample, where seven 
psychoses emerged (4.7%), and the high-risk status did not predict psychosis at 12-
month follow-up. Hospital admissions for psychotic disorder were predicted by SIPS 
positive symptom factor and PQ depersonalization factor, but not by CHR status. Any 
psychiatric hospitalizations were predicted by CHR status, SIPS positive and general 
symptom factors, and PQ role functioning factor.  
Rates of suicidal ideation and suicidal thoughts were high among adolescents in 
psychiatric care. Current suicidality was higher in the CHR group compared to the non-
CHR group. Further, decreased expression of emotions predicted self-harm during 
follow-up. This symptom may be indicative of a higher risk to suicide among girls 
seeking help in psychiatric clinics and wards. 
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To sum up, patients in a non-selected public health care sample reported a lot of 
psychotic-like symptoms, especially delusional ideas, perceptual abnormalities, and 
suspiciousness. Although only modestly predictive of psychosis, psychotic-like 
symptoms can indicate a more serious disorder, represented as cognitive deficits, 
suicidality, and psychiatric hospitalization in the following years. Depersonalization 
symptoms, anomalies of self-experience such as a feeling of being outside of own body 
or living in a dreamlike world, can be indicative of a higher risk to later psychosis. 
 
5.2 Cognition and psychosis risk (Study I) 
Adolescents in psychiatric care presented with high levels of psychotic-like symptoms. 
Unusual thought content, suspiciousness, and perceptual abnormalities were among the 
commonly reported psychotic-like experiences in the interviewed sample. The 
adolescents maybe felt that something odd was going on and that something was wrong, 
or felt like others could read their mind, or had superstitious, magical thinking. It was 
also common that the young person reported feeling suspicious and being watched by 
others. Of the hallucinations, the adolescents typically said in the interview that they 
had started hearing some kind of banging or someone calling their name, or even voices 
saying what they should do. Some reported seeing figures or shadows or even people 
that were not really there.  
However, grandiosity, the feeling of having special gifts or having been chosen for a 
special role, was seldom scored among the participants, which is consistent with 
previous results (Hawkins, McGlashan et al., 2004; Lencz et al., 2004). Disorganized 
communication, difficulties getting their point across because of rambling or blanking 
out, was another positive symptom not scored as often as the other positive symptoms. 
The factorial structure of the SIPS instrument was confirmed, as the finding of this 
study was similar to the factorial structure obtained by other study groups (Comparelli 
et al., 2011; Hawkins, McGlashan et al., 2004; Jung et al., 2010). Factor 1 consisted of 
non-specific distress symptoms. All symptoms classified as positive within the SIPS 
loaded principally on factor 2, along with “Bizarre thinking” which is classified as a 
disorganization symptom in the SIPS. Factor 3 reflected negative symptoms.  
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Those subscales thought to measure disorganization symptoms in the SIPS interview 
did not form a separate factor in the analyses of this study, but were scattered in the 
three factors: in addition to the above-mentioned D2 “Bizarre thinking” loading to 
positive symptom factor, subscale D3 “Trouble with focus and attention” loaded to 
general symptom factor, and D1 “Odd behavior or appearance” and D4 “Personal 
hygiene / social attentiveness” to negative symptom factor. This is consistent with 
earlier findings and indicates the somewhat vague nature of the disorganization 
symptoms that do not form a separable cluster. Disorganization symptoms may also 
emerge more seldom in adolescents in the early course of psychiatric illness compared 
to patients with more severe psychosis risk or established psychosis. 
Psychosis risk status was associated with weaker visuospatial task performance 
among adolescent psychiatric patients. This result is consistent with earlier findings. 
Visuospatial performance has been shown to be impaired among clinical or familial 
high-risk subjects (Bora et al., 2014) and specifically among those who later develop 
psychosis (Brewer et al., 2005; Jones et al., 1994; Niendam et al., 2003; Tiihonen et al., 
2005; Wood et al., 2003). However, some studies have not found visuospatial 
performance to be impaired in psychosis risk patients (Hawkins et al., 2004; Lencz et al., 
2006; Niendam et al., 2006). The differences in the results can possibly be explained by 
the fact that the definition of the visuospatial domain varies and it is measured with 
different sets of neurocognitive tests across studies. In sum, however, it appears that the 
visuospatial domain of cognition may be a vulnerability marker for being at risk for 
psychosis, and possibly a marker for onset of psychosis. 
Negative symptoms appear to be closely linked to cognitive performance, affecting 
everyday functioning. In the CHR group, deficits in cognitive functioning were 
associated with stronger negative symptoms. There was also a connection between 
negative symptoms and poorer verbal performance in the non-CHR group, suggesting 
that along the whole continuum of negative symptoms there is a connection with verbal 
performance deficits. Negative symptoms include lack of motivation, persistence, and 
energy, therefore possibly influencing the results of cognitive testing. Among patients 
with psychosis, negative symptoms have been found to be associated with deficits in 
cognitive performance (Ohmuro et al., 2015), especially in processing speed (Cameron 
et al., 2002; Cuesta & Peralta, 1995; O'Leary et al., 2000; Rhinewine et al., 2005) and 
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verbal performance (Dominguez et al., 2009; Liddle, 1987; O'Leary et al., 2000). 
Negative symptoms were also associated with slower information processing speed in a 
general population sample of female twins (Simons et al., 2007).  
Negative symptoms and cognitive deficits may not only have a special role in 
predicting transition to psychosis, but they may also be related to the severity and 
outcome of psychiatric disorder regardless of the psychosis risk status, as cognitive 
deficits are associated with reduced functioning (Lin et al., 2011) and poor outcome 
among first-episode schizophrenia patients (Bilder et al., 2000). It is therefore essential 
to pay attention to negative symptoms among all help-seeking adolescents. Although 
manifested separately as negative symptoms and cognitive difficulties, the underlying 
processes may perhaps be converging. Negative symptoms may also mediate the 
relationship between cognitive performance and functional outcome (Meyer et al., 2014; 
Ventura et al., 2009), suggesting need for rehabilitation targeting both negative 
symptoms and cognitive deficits as a means of enhancing functioning. Cognitive 
remediation has been found to improve the cognitive performance of schizophrenia, and 
in recent years this approach has also started to yield interest in high-risk research 
(Zaytseva, Korsakova, Agius, & Gurovich, 2013).  
It is also important to identify positive symptoms among adolescent patients because 
even mild positive symptoms can have associations with cognitive functioning, and thus 
inform about a more serious disorder. In this study, positive symptoms, and especially 
P4 “Perceptual abnormalities and hallucinations”, were associated with poorer 
visuospatial performance in the non-CHR group. Mood and anxiety disorders were 
common in this group, and cognitive impairment is common among these disorders 
(Castaneda, Tuulio-Henriksson, Marttunen, Suvisaari, & Lönnqvist, 2008), as are 
subpsychotic hallucinations (Gaudiano & Zimmerman, 2013; Rietdijk et al., 2014). One 
earlier study has found positive symptoms to be associated with slower reaction speed 
in a general population sample of female twins (Simons et al., 2007), and another with 
memory and attention impairment in schizophrenia patients (Talreja et al., 2013). Both 
cognitive deficits and psychotic-like symptoms cluster in families of schizophrenia 
patients, suggesting shared genetic factors behind them. In a systematic review, 
processing speed was the only domain with a significant correlation to positive 
symptoms (Dominguez et al., 2009). However, according to the majority of earlier 
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research, compared to other symptom domains, positive symptoms interfere less with 
cognitive functioning (Ventura et al., 2009). 
 
5.3 Predictiveness of the SIPS interview (Study II) 
Based on the SIPS interview, one third of the pre-screened adolescent psychiatric 
patients belonged to a group of heightened psychosis risk. However, the significance of 
the high-risk status was limited in predicting psychosis. Psychosis incidence was low 
among these adolescents who had mostly sought help for depression and anxiety rather 
than for positive symptoms.  
The matter of differences in defining psychosis is important in the field of psychosis 
research. The definitions of psychosis and psychosis risk state differ between SIPS, 
CAARMS, ICD-10, and DSM-IV or DSM-5 (Fusar-Poli & van Os, 2013; Miller et al., 
2003; Olsen & Rosenbaum, 2006a), and different definitions of psychosis lead to 
different transition risks (Fusar-Poli, Bonoldi et al., 2012; Schultze-Lutter et al., 2013). 
The same symptoms can be interpreted in different ways depending on the approach, as 
demonstrated with a case description by Fusar-Poli and van Os (2013).  
For instance, DSM-IV and DSM-5 diagnostic criteria for brief psychotic disorder 
include the presence of psychotic symptoms, with a duration of at least a day but less 
than a month, but there are no requirements for lowered functioning. The definition of 
psychosis in the SIPS is stricter, and an absence of insight is required for the symptom 
to be rated as psychotic. If the person realizes that an experience is not true, the 
symptom is not rated as psychotic. The enhancement of insight has traditionally often 
been the goal of treatment as it is associated with quality of life and outcome. A part of 
insight is realizing that hallucinations or delusions are pathological. However, insight is 
continuous and fluctuating by nature (McGorry and McConville, 1999). 
Both SIPS and DSM-IV definitions for psychosis were used in this study because of 
the difference in definitions. However, the results were quite similar using both 
approaches. Depending on the definition of psychosis, there were three or five new 
conversions to psychosis during the one-year follow-up time.  
Compared to international studies conducted in specialized early intervention clinics 
with patients preselected based on suspicion of a psychosis risk (Cannon et al., 2008; 
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Ruhrmann et al., 2010), lower transition rates were observed in an unselected sample of 
adolescents with a first admission to psychiatric services, as expected by Fusar-Poli, 
Borgwardt and colleagues (2013). High transition rates in many high-risk studies have 
been suggested to reflect sampling strategies more than the specific high-risk criteria 
(Fusar-Poli, Yung et al., 2014). The more enriched the sample is, the more effective the 
CHR approach is to detect psychoses. In addition, in some recent high-risk research 
papers, it has been stressed that the low conversion rates in some studies can also be 
related to careful exclusion of psychotic persons at baseline (Fusar-Poli & van Os, 
2013). If the positive symptoms of a person fluctuate, they can be at a subpsychotic 
level in one assessment and at a psychotic level in the next one, thus interpreted 
incorrectly as transition to psychosis in some studies. 
Though the validity of the CHR status was limited in predicting psychoses at 12 
months, the predictive value of the psychotic-like symptoms appeared on a longer high 
coverage hospitalization register follow-up. The intensity of the positive, psychotic-like 
symptoms predicted psychiatric hospitalizations due to psychosis. The result is 
consistent with several (Cannon et al., 2008; Haroun et al., 2006; Ruhrmann et al., 2010; 
Werbeloff et al., 2012) but not all (Simon & Umbricht, 2010; Ziermans et al., 2011) 
earlier studies.  
The important difference between the intensity of positive symptoms and CHR status 
is that symptom worsening is required for CHR. Another reason why positive symptoms 
predicted psychosis but CHR did not may be that for CHR status, positive symptoms 
can range from moderate to severe, and the information of the severity of the symptoms 
gets lost in the CHR/non-CHR coding. 
Another issue is that the positive symptom factor loaded with positive symptom 
items and, in addition, with “Bizarre thinking”, which is a disorganization symptom in 
the SIPS (Table 12). Bizarre thoughts were quite rare in this study sample, but when 
they occurred they had a significant role. The EPOS study, a large European multi-
center field study, has also found the best predictors of conversion to psychosis to be 
“Bizarre thinking” in addition to positive symptom items (Ruhrmann et al., 2010). 
“Bizarre thinking” in the SIPS is conceptualized as absurd, illogical ideas, either 
reported by the interviewee or observed by others (and difficult for them to understand). 
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The person may have strange, unusual ideas that violate the boundaries of physics that 
do not fit their subculture, for example the religion of the person. 
In addition, the CHR status as well as positive and general symptoms predicted all 
psychiatric hospitalizations. This finding is consistent with a connection found between 
attenuated psychotic symptoms and psychiatric hospitalizations later in life among 
young adults in the general population (Werbeloff et al., 2012). Psychotic-like 
symptoms may hence be general predictors of later severe psychiatric illness requiring 
hospitalization. 
The prevalence of transition to psychosis among adolescent psychiatric patients was 
relatively low in this study. One possible explanation for this is the effectiveness of the 
treatment received at the psychiatric clinics and wards. Antidepressive medication 
(Cornblatt et al., 2007; Cornblatt, 2002) or antipsychotics (Addington & Heinssen, 2012; 
Correll et al., 2010) can lower the psychosis risk of adolescents with risk symptoms, and 
the same has been observed for cognitive psychotherapy (Okuzawa et al., 2014).  
On the other hand, it is possible that the current treatment system does not reach all 
adolescents with psychosis risk symptoms. Adolescents tend to have little knowledge 
about mental health problems and experience, and find seeking help for them 
stigmatizing (Yap, Reavley, & Jorm, 2013). Parental knowledge of and attitudes 
towards mental health services affect the swiftness of getting help (Chen, Gearing, 
DeVylder, & Oh, 2014). Especially boys with externalizing symptoms, low functioning, 
negative symptoms, and odd behavior may not seek help inasmuch as girls with 
internalizing symptoms such as depression and anxiety.  
Low threshold care in the adolescent’s own network has proved to work well in 
reducing stress and supporting the functioning of symptomatic adolescents in Finland 
(Granö et al., 2009). Every young person should get the care they need without stigma, 
and young people’s awareness of mental health should be enchanced (The International 
Declaration on Youth Mental Health, 2013). 
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5.4 Predictiveness of the PQ questionnaire (Study III) 
Several specific questionnaires have been constructed for the screening of psychotic 
symptoms and selection of patients for targeted interviews. In this study, the Prodromal 
Questionnaire (PQ) was used. Endorsement rates were high for most symptoms of the 
PQ, consistent with other studies finding psychotic-like symptoms measured with 
questionnaires common among non-psychotic help-seekers (Brandizzi et al., 2014; 
Hanssen et al., 2003; Yung et al., 2006).  
 In a Dutch study, virtually all respondents in a non-psychotic help-seeking 
population reported at least one item on the positive symptom scale of the PQ (Rietdijk 
et al., 2014). In their study, four classes of psychotic-like experiences were found 
(normative, mild, moderate, and severe), replicating the finding of four class structures 
of the psychosis phenotype found earlier in the population (Rietdijk et al., 2014). In 
another study conducted among help-seeking adolescents in Italy, the psychotic-like 
experiences measured with the PQ formed four factors interpreted as “conceptual 
disorganization and suspiciousness”, “perceptual abnormalities”, “bizarre experiences”, 
and “magical ideation”, with only the first factor related to psychopathology, as 
measured with the negative, general, and disorganization scales of the PQ (Brandizzi et 
al., 2014).  
In prospectively testing the predictiveness of the PQ in the adolescent sample of this 
study, it was found that many adolescents with low PQ scores were also hospitalized for 
psychosis during the follow-up (false negatives), leading to a low predictive value of the 
questionnaire. Although the PQ is sometimes used in clinical settings for strict 
screening of psychosis risk without any second-stage clinical interview, using PQ on its 
own cannot be recommended, as previously published cut-off scores were poor 
predictors of psychosis. Hence, the idea of a two-phase assessment procedure, with PQ 
as an initial screen for a more rigorous interview-based risk assessment, is supported. 
However, the structural validity of the Finnish language PQ was supported through 
nine interpretable latent factors, of which role functioning predicted hospital treatments 
for any psychiatric disorder during follow-up. PQ items loading to role functioning 
reflect issues of everyday ability to function, such as problems at school and trouble 
concentrating or getting things done. It is not very surprising that this baseline 
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functioning factor predicts hospitalizations, an outcome indicating illness severity and 
deterioration in functioning during follow-up. 
Further, the depersonalization factor predicted psychosis. Depersonalization 
symptoms, such as feeling less real or dreamlike or watching oneself act, though not 
specifically scored in the clinical high-risk approach, were common among the 
interviewed adolescents. The adolescents sometimes said in the interview that they felt 
like they had changed and everything felt unreal. A sense of distance from the world or 
from oneself was described by some participants; they felt disconnected from 
themselves or from their lives. These experiences were sometimes reported in the N4 
“Decreased experience of emotions and self” part of the SIPS interview, sometimes 
spontaneously during the interview, as distracting experiences affecting everyday living.  
Depersonalization occurs along a continuum, with short-lasting episodes being a part 
of normal experience, and long-lasting and disabling episodes as an extreme form of the 
phenomenon. The finding of depersonalization symptoms associating with psychosis is 
consistent with the theory of multisensory integration deficits in schizophrenia affecting 
self-experience (Postmes et al., 2014). Perceptual incoherence in psychosis can evoke 
depersonalization and other anomalous self-experiences (Postmes et al., 2014).  
As a concept close to depersonalization, dissociation has been found to be linked to 
self-reported psychotic-like experiences (Moskowitz, Barker-Collo, & Ellson, 2005). 
Among healthy subjects, depersonalization predicted proneness to hallucinations, 
supporting the idea of hallucinations as a product of dissociative processes splitting 
positions of the self apart (Perona-Garcelán et al., 2013). 
Psychosis risk symptoms have been found to be associated with a high prevalence of 
childhood trauma (Kraan, Velthorst, Smit, de Haan, & van der Gaag, 2015), which in 
turn is linked to depersonalization (Vermetten & Spiegel, 2014). Among psychosis risk 
patients, levels of self-disturbances have been found to predict psychosis onset (Nelson, 
Thompson, & Yung, 2012; Parnas et al., 2011). Incoherencies in self-experience are a 
common characteristic preceding psychosis onset, strengthened and thematized in the 
form of delusions and hallucinations in the transition to frank psychosis (Parnas & 
Handest, 2003; Raballo, 2012).  
Depersonalization can thus be seen as an important psychosis vulnerability 
phenotype. Though not specifically included in the SIPS or CAARMS interviews, 
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depersonalization has been covered in the basic symptoms approach as one of the 
psychosis risk experiences (Klosterkötter et al., 2001).  
It has been stated that assessing these kinds of symptoms with a self-disturbance 
measure would be a valuable asset to psychosis risk identification in addition to the 
CHR/UHR strategy (Nelson et al., 2012). In addition, early psychosis intervention could 
include diminished concentration on depersonalization experiences, thus affecting the 
hallucination proneness, as focusing on these experiences tends to strengthen them 
further (Perona-Garcelán et al., 2013). 
 
5.5 Self-harm and psychosis risk (Study IV) 
In the baseline assessment of this study, a continuous model of suicidality was used, 
reflecting the full continuum from suicidal ideation to self-harm. Information was 
collected on suicidal thoughts and behavior from interviews and medical records. As it 
was found to be incorrect to suggest that suicidal intention was related to hospitalization 
(for instance, absent in a case of cutting when it did not lead to hospitalization and 
present in an overdose with hospital admission), all self-harm was analyzed as a whole, 
regardless of intention, which was not formerly assessed in this study.  
In contrast, the register outcome status used was dichotomous in a Yes/No format. 
The self-harm cases cannot be referred to as suicide attempts as there was no evidence 
of suicidal intent among the self-harm incidents. Hospital presentations for self-
injurious behavior can be motivated by other factors than intention to die. The data of 
intentional self-harm leading to hospitalization was combined with data of completed 
suicide during follow-up. Altogether, five girls harmed themselves during follow-up.  
Psychosis risk status was significantly associated with more severe baseline 
suicidality, consistent with previous results (DeVylder et al., 2012; Granö et al., 2013; 
Hutton et al., 2011). Depending on the suicidality measure used, 78–83% of the CHR 
group was at least mildly suicidal and 35% had harmed themselves before baseline.  
Current suicidality was associated with delusions, suspiciousness, and hallucinations, 
paralleling the findings of a large population study by Saha and colleagues (2011), 
where a dose-response relationship between delusional-like experiences and suicidality 
was found. Furthermore, in their study, there was also an association between 
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delusional-like experiences and suicide attempts among those with a history of any 
mental disorder (Saha et al., 2011). Similarly, in a previous study conducted among 
adolescents with more severe suicidal behavior (plans or acts), the majority reported 
psychotic-like symptoms (Kelleher et al., 2012). Among adolescents with depressive 
disorders, those who also experienced psychotic-like symptoms had nearly 14-fold 
increased odds of more severe suicidal behavior, compared with adolescents who did 
not experience psychotic-like symptoms (Kelleher et al., 2012). Among adolescent 
students, psychotic-like symptoms were associated with a higher risk of suicidality and 
this was especially true if the symptoms were accompanied with distress and poor help-
seeking behavior (Nishida et al., 2014).  
In sum, psychotic-like experiences seem to be a risk marker of suicidality. Instead of 
a direct causal association, a third factor may be behind both psychotic-like experiences 
and suicidality, possibly some kind of general psychological distress or stressful or 
traumatic life experiences (Saha et al., 2011). Psychotic-like experiences can indicate a 
more serious non-psychotic disorder, often also manifesting as suicidal ideation and/or 
self-injury.  
Girls reported more current suicidal ideation compared to boys, which is in line with 
previous results (Delfabbro et al., 2013; Hawton et al., 2012; Schrijvers et al., 2012). 
The associations between lifetime suicidality and substance misuse of a first-degree 
relative and troubled family background are consistent with previous research 
(Delfabbro et al., 2013; Hawton et al., 2012). The association can possibly be explained 
by traumatic childhood experiences. Dysfunctional parenting has been found to be 
somewhat associated with psychopathology non-specifically and the association seems 
at least partly causal (Kendler & Prescott, 2006). As another environmental risk factor, 
loss of a parent by death or divorce is associated with an increased risk for mood, 
anxiety, and substance use disorders (Kendler & Prescott, 2006). It has been found in 
other studies that adolescents with separated parents tend to be more suicidal than those 
with intact families (Delfabbro et al., 2013; Hawton et al., 2012). 
Not surprisingly, there was a higher risk for suicidality among those with a mood 
disorder at baseline compared to those without a mood disorder. Depressive symptom 
severity, as measured with the BDI, was also positively correlated with baseline 
suicidality. According to a large WHO study, mood disorders are the strongest 
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predictors of suicide attempts in developed countries (Nock et al., 2009). Continuing 
mood disorder also predicted suicidal behavior among adolescent outpatients (Tuisku, 
Pelkonen, Kiviruusu, Karlsson, & Marttunen, 2012). In a review, depressive symptoms 
were among the best predictors of adolescent suicidality (Hawton et al., 2012). Further, 
severity of self-rated depressive symptoms differentiated suicidal children and 
adolescents from non-suicidal among depressive patients (Hetrick, Parker, Robinson, 
Hall, & Vance, 2012). Among depressed adolescent outpatients, those with deliberate 
self-harm had more severe depressive symptoms than those without self-harm (Tuisku 
et al., 2009). In addition, adolescents with suicidal ideation or suicide attempts had more 
depressive and anxiety symptoms than adolescents with self-harm without intention to 
die (Tuisku et al., 2009). 
In this study, all the patients with intentional self-harm during follow-up were girls. 
The prevalence of self-harm (3.2%) was low and closer to the prevalence of suicide 
attempts found in the population (Nock et al., 2013; Riala et al., 2007) than in 
psychiatric samples. However, in this study, history of self-harm was not assessed in an 
interview as in previous studies, but all cases resulted in hospital care. The low 
prevalence of self-harm in this study can be explained by the fact that self-harm is 
suspected to be much more common in the community than presenting at clinical 
services, and only a small proportion of individuals who self-harm ever need hospital 
care (Hawton et al., 2012). 
 This study also explored the Causes of Death statistics (Statistics Finland) and was 
able to systematically follow 758 adolescents who completed the PQ at baseline. In the 
whole group, there were six deaths (0.8%) until 2012, three of which were suicides. 
Only one of these adolescents was included in the interviewed sample of 161 patients. 
Deaths were thus rare in this adolescent psychiatric sample, although a third fulfilled the 
criteria for clinical high-risk state. Low suicide risk during the follow-up suggests a high 
quality of care in these adolescent psychiatric services.  
Decreased expression of emotions, which in the SIPS is regarded as a negative 
symptom, may indicate an elevated risk of severe suicidal behavior among adolescent 
psychiatric patients. This scale of the SIPS can be seen as related to alexithymia, 
characterized by an inability to identify and describe emotions leading to dysfunction in 
empathy, emotional responding, and social attachment (Sifneos, 1996). Alexithymic 
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individuals also suffer from affective dysregulation, part of which is emotional 
inexpressivity, and alexithymia may lessen the capacity to cope with emotional stressors. 
Alexithymic features have been found to be positively associated with depression 
(Honkalampi et al., 2009; Manninen et al., 2011) and suicidal ideation (De Berardis et 
al., 2013; Garisch & Wilson, 2010; Verrocchio, Conti, & Fulcheri, 2010).  
Further, female college students with frequent deliberate self-harm have been found 
to report high levels of emotion dysregulation and emotional inexpressivity (Gratz, 2006; 
Gratz & Roemer, 2008). It has been discussed that self-harm may function as a 
maladaptive way to express distressing emotions that the person is unable to otherwise 
express, or to avoid difficult emotions (Gratz & Roemer, 2008).  
 
5.6 The heterogeneity of psychotic-like symptoms 
Psychosis risk patients are not a homogeneous group as only a small portion of them 
will develop psychosis. Though more research is needed into which symptoms best 
predict psychosis, it can be said with certainty that not all persons with psychotic-like 
experiences are at risk for psychosis. These experiences are common among adolescents 
and adults in psychiatric care (Hanssen et al., 2003; Rietdijk et al., 2014; Yung et al., 
2006). Even in population samples, infrequent psychotic-like experiences have been 
reported by a large proportion of the respondents (van Os, Hanssen, Bijl, & Vollebergh, 
2001; Yung et al., 2009). When infrequent and not distracting, psychotic-like symptoms 
are not associated with a psychosis risk. This reflects the heterogeneity of attenuated 
psychotic experiences. It also has to be kept in mind that all psychotic-like symptoms 
are not of the same value. Even though psychotic experiences form a continuum, 
psychosis risk assessment is categorical and based on a cut-off point. A positive 
symptom rated as five is much more severe than one rated as three in the SIPS, yet they 
both indicate psychosis risk status according to the clinical high-risk approach.  
Alison Yung (2009) has suggested that positive symptoms can be divided into three 
classes which may be: 1) predictive of psychosis, or 2) “clinical noise” related to non-
psychotic disorders, or, 3) if not distracting, just variation of the psychosis continuum 
presenting in a healthy population. In the sample of this study, it seemed that most of 
the positive symptoms reported belonged to the second group. The psychotic-like 
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symptoms of the adolescents seemed to be “clinical noise” as a part of their 
symptomatology associated with the depressive, anxiety, and other symptoms that the 
adolescents were suffering from.  
Psychosis risk state is especially often comorbid with anxiety and depressive 
disorders (Fusar-Poli, Nelson et al., 2014). When treating the presenting symptoms, the 
positive symptoms also tend to relieve (Wigman et al., 2011; Yung, Nelson, Thompson 
et al., 2010b). Nevertheless, comorbidity of psychotic-like symptoms and depression 
can be a sign of a more severe illness with worse treatment prognosis (Wigman et al., 
2012), and comorbidity also adds the risk of suicidality among psychosis risk patients 
(Fusar-Poli, Nelson et al., 2014). In one study, following up risk patients with comorbid 
disorders, non-psychotic bipolar disorders were associated with increased and anxiety 
disorders with reduced psychosis risk, while depressive disorders were not associated 
with transition (Salokangas et al., 2012).  
Although psychotic-like symptoms in the Helsinki Prodromal Study did not 
specifically predict psychosis to the extent it was expected, they can be associated with 
other clinical outcomes, such as suicidality. They also predicted psychiatric 
hospitalizations unspecifically. In a delinquent adolescent population, the psychosis risk 
status did not predict psychosis either; however, the risk status was associated with 
other psychiatric problems, such as symptoms of anxiety and depression, and mood and 
substance-related diagnoses (Manninen et al., 2014). Transition from the risk state to 
various disorders, such as mood disorders, is considered significant in the current field 
of high-risk research (Fusar-Poli, Yung et al., 2014). In the clinical staging model, the 
focus is not on a specific diagnosis but on deterioration of functioning. Each patient is 
staged on the continuum of mental illness course, aiming at individualized treatment 
and reducing the risk of progression to the next stage (Cross et al., 2014). 
 
5.7 Psychotic-like symptoms in the clinical setting 
When treating adolescent psychiatric patients, monitoring psychotic-like symptoms is 
significant. Longer duration of psychosis risk symptoms without treatment is associated 
with a higher transition rate to psychosis, indicating the importance of detecting risk 
patients and prompt referral to psychiatric care (Nelson et al., 2013; von Reventlow et 
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al., 2014). In early detection of adolescent psychosis risk, the role of general medical 
practice is important, whereas the sustained psychosocial and pharmacological 
treatment of first-episode psychosis belongs to specialized care (Mäki & Veijola, 2012).  
General guidelines can be given of when psychotic-like symptoms might be 
alarming. These situations include severe, distracting positive symptoms that worsen 
with time. Because of the commonness of the experiences, it is the distress associated 
with them that matters, or if the symptom starts affecting the behavior of the person. 
Psychotic-like symptoms that are associated with lowered functioning, negative 
symptoms, or genetic risk to psychosis should raise the clinician’s concern. Frequent 
monitoring of the young person with risk symptoms is recommended, so that the 
worsening of the symptoms gets noticed. Adolescent-onset psychosis tends to start 
gradually with subtle changes in behavior and symptoms so that there may be delay in 
treatment (Joa et al., 2009). 
However, identifying and treating psychotic-like symptoms is important not just for 
the sake of psychosis prediction. Regardless of the symptoms being predictive of 
psychosis or not, they deserve attention in their own right, as they cause distress and 
affect quality of life and level of functioning (Addington & van der Gaag, 2015). 
Psychotic-like symptoms are associated with persistent disability even among those 
who do not convert to psychosis (Addington et al., 2011; Haroun et al., 2006). 
Especially paranoia may be linked to e.g. low or unstable self-esteem (Thewissen et al., 
2007), shame (Johnson et al., 2014), and traumatic memories (Pinto-Gouveia, Matos, 
Castilho, & Xavier, 2014).  
Clinicians should try to understand what the symptoms are about and how they can 
help to understand the situation of the young person. Asking about psychotic-like 
symptoms directly from adolescent psychiatric patients is therefore essential. Psychotic-
like symptoms are confusing, possibly frightening experiences that may not be visible to 
others and that the adolescents may not spontaneously reveal, and as a consequence, 
they can often be left unnoticed in clinical settings. A questionnaire like the PQ or a 
semi-structured interview like the SIPS offer good opportunities to go through the 
symptoms systematically. Asking about psychotic-like symptoms directly and 
verbalizing them tells the adolescent that similar symptoms are experienced by other 
people too. Just talking about the experiences for the first time can therefore be 
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relieving. In the treatment system, it may even be somewhat secondary to categorize 
patients according to diagnosis or psychosis risk status; instead, the symptoms presented 
by the person and how they affect his or her life should be the focus. 
In the treatment of psychosis risk patients, symptoms could be relieved and the risk 
of transition to psychosis lowered with a combination of antipsychotics and therapy 
according to some studies (Addington & Heinssen, 2012; van der Gaag et al., 2013). 
However, with high false-positive rates and side-effects, antipsychotic medication is not 
recommended for people considered to be at increased psychosis risk (Addington & van 
der Gaag, 2015; National Institute for Health and Care Excellence, NICE, 2014), and 
psychosis risk research is problematically influenced by the large proportion of 
prepsychotic individuals in the USA who are medicated with them (McGorry, Yung, 
Bechdolf, & Amminger, 2008). In the NICE guidance, individual cognitive behavioral 
therapy (CBT) with or without family intervention is recommended to a person at 
increased risk of developing psychosis. In addition, mood, anxiety, and other disorders 
that the risk individuals often have are treated according to the clinical guidelines of 
these disorders (National Institute for Health and Care Excellence, 2014). 
In a meta-analysis, transition to psychosis was found to be reduced with the use of 
CBT, omega-3 fatty acids, and integrated psychotherapy (Stafford, Jackson, Mayo-
Wilson, Morrison, & Kendall, 2013). A recent study found that combined with CBT, 
antidepressants were more effective than antipsychotics in reducing transition to 
psychosis among psychosis risk patients (Fusar-Poli, Frascarelli et al., 2014). In another 
study, family-aided assertive community treatment yielded good results in reducing 
symptoms and improving functioning of high-risk and early psychosis participants 
during a two-year follow-up (McFarlane et al., 2015). 
Psychosocial treatments and efforts to keep risk patients involved with social 
networks, “on track in a shared reality”, are currently being recommended (Addington 
& van der Gaag, 2015). Specifically, CBT has been found to effectively reduce 
transition rates to psychosis in some studies, but the effect is not always long-lasting 
(Okuzawa et al., 2014). 
The cognitive approach to treating psychotic(like) experiences includes 
normalization and adaptive interpretation of them. It aims to reduce stress, emphasizing 
that the patient’s fear of “being mad” can be more distressing than the experience itself 
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(Morrison, Renton, Dunn, Williams, & Bentall, 2004; Morrison et al., 2012). 
Eliminating the symptoms is thus not the primary goal of cognitive therapy, but 
reducing the distress that is associated with the symptoms. Cognitive therapy recognizes 
the biases in perception and reasoning related to the symptoms, and how the experiences 
often are somehow functional for the individual (Morrison et al., 2004). The 
experiences, for instance hallucinations, are maintained by misinterpretations, and 
interpreting them in a more adaptive way reduces fear and depression, hence improving 
the prognosis (Krabbendam et al., 2005; Morrison et al., 2004). In therapy, a case 
formulation of what may have caused the problem and what is maintaining it is essential 
(Anttonen, 2004; Morrison et al., 2004; Määttä & Anttonen, 2013). Enhancing 
alternative explanations for the odd experiences may prevent transition to psychosis 
among CHR individuals (Addington & van der Gaag, 2015). Treating positive 
symptoms, other symptoms can also be reduced; for example, in a case where a 
disturbing voice interferes with sleeping or concentration. 
 
5.8 Strengths and limitations 
5.8.1 Strengths of the study 
The topic of this study was rather new with an unselected sample of first-admission 
adolescent patients in general psychiatric care. Because many psychosis risk study 
samples have been derived from highly specialized clinics, it is difficult to estimate how 
representative they are of patients encountered in a non-selected clinical setting. Further, 
this study used help-seeking adolescents who did not meet the CHR criteria as a 
comparison group, which gave a better chance of group comparisons than using healthy 
controls. In addition, a healthy control group was enrolled for cognitive performance. 
The participants of this study were aged 15–18, representing the middle adolescence 
stage, the phase with an elevated risk for psychosis.  
Although the interviewed subsample was smaller, the sample with questionnaire data 
was quite large with over 700 youths. The strengths of this study also include the long 
follow-up using the Finnish Hospital Discharge Register, with good accuracy in 
detecting psychoses (Perälä et al., 2007). 
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5.8.2 Limitations of the study 
In the sample of this study, two-thirds were girls, reflecting the gender distribution 
among adolescent psychiatric patients. Boys with psychosis risk symptoms were 
unfortunately not fully represented in this sample. In order to reduce the statistical 
analyses, factors of symptoms and cognitive performance were used, which can be seen 
as a limitation.  
Follow-up assessment including SIPS interview was only done with a small subset, 
and transition to psychosis was often established using high quality medical records 
including outpatient records. The definition of psychosis varies across approaches, and 
categorizing a variable of a continuous nature can lead to some obscurities (Fusar-Poli 
& van Os, 2013). In this study, using SIPS and DSM-IV criteria of psychosis resulted in 
slightly different rates of transition. 
The approximated 25% rate of Prodromal Questionnaire drop-outs among patients 
selected for inclusion can be considered acceptable. It may be accounted for by a failure 
of the clinic personnel to present the questionnaire to the patient, or the patient not 
coming in for their second appointment, or possible refusal to fill in the form. The 
original Prodromal Questionnaire was used. It does not include distress and frequency 
of the symptoms that the revised version measures (Loewy et al., 2007).  
The study concerning suicidality was of an explorative nature, and lifetime 
suicidality was not assessed formally. The results of self-harm during follow-up only 
represent the most severe forms of suicidal behavior, as the hospital discharge register 
data does not illustrate the whole spectrum of suicidality. 
Assessing symptoms in the high-risk approach is not a simple field, and there is a 
thin line between psychotic and severe but subpsychotic symptoms. When close to 
psychosis, it may be difficult to estimate how convinced the person is of the experiences 
and whether the symptoms should be rated at a psychotic or a subpsychotic level. The 
spectrum of adolescent symptomatology is wide, and it can be challenging to separate, 
for instance, panic attacks with extreme symptoms, dissociative symptoms, or severe 
obsessive-compulsive symptoms from psychotic episodes.  
The issue of symptomatic overlaps has not been left unnoticed by another study 
group of Simon and colleagues (2014), who describe patients encountered in early 
psychosis services to present with various symptoms not expressing true psychosis risk. 
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These symptoms include, for instance, depersonalization, obsessive-compulsive 
symptoms, and hallucinations. The authors state that instead of merely defining the 
psychosis risk status, the “gestalt” of the symptoms has to be assessed, in order to 
evaluate if the person really is at heightened psychosis risk (Simon et al., 2014). 
 
5.9 Future research recommendations 
After gathering data on cognitive performance at baseline and on predicting psychosis 
and psychiatric hospital care with the SIPS interview, the next research question is the 
association between cognitive performance and later transition to psychosis and 
psychiatric hospital care. Further, a prediction algorithm combining all available 
information in this study (screening questionnaire, interviews, functioning measures, 
and cognitive performance) could be created, similar to those reported by other high-
risk research centers.  
Depersonalization symptoms, feelings of unreality and strangeness, were 
qualitatively important in the symptomatology of many young psychiatric patients and 
statistically significantly predictive of psychosis, though they are not systematically 
assessed in clinical high-risk research. Therefore, it would be useful to investigate 
depersonalization symptoms further. Another specific area of further research is 
decreased expression of emotions, which predicted self-harm in this study.  
Further, investigating how young people at true psychosis risk are being caught by 
the treatment system is an area worthy of future research. The paths to treatment in 
cases of established psychosis could be retrospectively analyzed. For example, males 
and females may have different kinds of paths to treatment and possible psychosis, with 
gender differences in seeking psychiatric care and later psychosis. This would help 
examine how the psychiatric service system could be improved to enable early 
intervention for adolescents with severe risk symptoms. Early detection of risk 
symptoms and early intervention is needed to prevent cognitive and psychosocial 
deficits developing in the prodromal phase of psychosis. 
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5.10 Clinical implications 
Although most persons with a psychotic disorder experience a prodromal period before 
the onset of psychotic-level symptoms, it is less clear how many persons who report 
psychotic-like symptoms will later develop a psychotic illness. False identification of a 
youth as prodromal can cause unnecessary concern and emotional harm through 
stigmatization, not to mention needless treatments especially if antipsychotics are used 
(Simon et al., 2011; Yung, Nelson, Thompson et al., 2010b). It is important to find a 
balance between, on one hand, discussing the psychosis risk with the patient and 
monitoring the risk and, on the other hand, normalizing the symptoms and reducing the 
anxiety of the patient (Broome & Fusar-Poli, 2012).  
Psychotic-like experiences occur in a wide range of disorders and they should not be 
mistaken to always indicate psychosis (Kelleher et al., 2014). As young people often 
react to stressors with psychotic-like symptoms, they may fall within the normal 
spectrum of experience of childhood and adolescence. In general psychiatric care, 
psychotic-like symptoms are less predictive of a specific psychosis outcome than in 
specialized prodromal clinics. In this study, a third of the adolescent psychiatric patients 
met criteria for a psychosis high-risk state. Of those screened positive in PQ, 40% were 
considered at risk, and of the screen-negative, 20%. After all, the majority of the risk 
cases were in fact false alarms: the person never converted to psychosis in spite of risk 
symptoms, at least during the follow-up time of this study project.  
However, the PQ and SIPS methods can be used to bring other useful information to 
clinical work. The PQ is especially used widely in clinical practice because it is easy to 
fill in and score without special training, and useful information on the psychosis risk 
symptoms experienced by the young person is obtained using the questionnaire. 
Psychotic experiences need clinical attention not only because they may predict 
psychosis but they are, by themselves, current, presenting symptoms. Further, 
psychotic-like symptoms do predict unspecific psychiatric hospitalizations, indicating 
illness severity and poor functional outcome. This result of the current study is in line 
with earlier results associating psychotic experiences with other mental disorders and 
psychiatric hospitalizations (Rössler et al., 2011; Werbeloff et al., 2012). 
CHR status is also associated with cognitive deficits and can indicate a more serious 
disorder limiting ability to function in everyday life. Even mild positive and negative 
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symptoms may have clinical relevance in psychiatric adolescent patients. Young people 
with both psychotic-like symptoms and neurocognitive deficits constitute a group in 
need of special attention. The association between suicidality and psychosis risk 
symptoms also emphasizes the importance of detecting psychotic-like symptoms among 
adolescents seeking psychiatric care. 
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